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THE COLLEGE OF
FAMILY PHYSICIANS
OF CANADA

LE COLLEGE DES
MEDECINS DE FAMILLE
DU CANADA

WHY FAMILY MEDICINE?
Famil y medi cine offe rs challenges, flexibili ty, and tremendo us di versity. Famil y ph ys icians provide comprehensive care for patients and
their fa milies w ithin the community, w ith a foc us o n preventio n, management of chroni c disease, and coordination of care. Famil y
ph ysicians have the oppo rtun ity to provide ca re in a variety of settings, including medi ca l clini cs, emergency departments, acute care
settings, and in patients' ho mes. So me work internationall y prov iding ca re to people in low-resource countries. With many physicians
workin g in tea ms and w ith other hea lth profess io nals such as nurses, occupatio nal therapi sts, and nutriti o ni sts, the field is also
beco ming more co ll abo rati ve.
Training for a career in family medicine
Famil y phys icians are often the first line of ca re and ca re fo r patients w hen they present w ith illness through the management of
c hroni c diseases.
Students shou ld consider fa mil y medi cine if they:
• Are interested in bei ng generali sts; famil y phys icians spec iali ze in breadth rather than depth of knowledge, amassing an equal but
diffe rent knowledge base to specia li sts
• Enj oy di agnos ing and managing the undifferentia ted patient: fa mily phys ic ians have the opportun ity to see patients from their first
prese ntatio n, and to manage their ca re both independentl y and in partnership w ith other medi ca l professio nals in the community
• Are attracted to a numbe r of di ffe rent specia lti es and wa nt their practi ces to enco mpass a w ide range of di sease presentations
• W ant fl ex ibili ty and co ntrol over their schedules
• W ant to fo rm lo ng-term relationships w ith their pati ents
Di ve rsi ty in patients, work setti ngs, and schedu les ma kes famil y med ic ine the most flex ible career in medi ci ne. A variety of practice
models, the opportuni ty to job share, and the abil ity to shape thei r practi ces offer fa mily ph ysicia ns a great dea l of choi ce. The high
demand for fa mily physicians in almost every regio n of Ca nada also opens many oppo rtunities fo r locum posi tio ns and travel.
Some fa mil y physic ians also choose to incorporate a focused area into thei r scope of practi ce. Nea rl y o ne-third of famil y medi cine
res idents compl ete additio nal training to better prepare them fo r the pati ents they wi ll encounter w hile serving thei r community's
specific needs.
Students may also pursue training through Enhanced Skills (R3) programs, ranging from a few mo nth s to o ne year. In 2008-2009, 196
R3 pos itio ns were ava il able in Ca nada fo r fa mi ly medi cine res idents. At so me schoo ls, prospec tive students ca n secure fundin g to
support an R3 training program based o n their unique ca ree r goa ls; ava il ability and foc us va ry by schoo l. Exa mples of Enhanced Ski ll s
programs include emergency medicine, sports medi c ine, geri atri cs, wo men' s hea lth (o bstetri cs, gynecology), adolescent medic ine,
mental hea lth, resea rch training, substance abuse treatment, intern ational hea lth, and HIV/ AIDS.
Income for family physicians varies w idely depending on hours, locatio n, incenti ves, and type of practi ce. Within a group practice,
family phys icians sho ul d ea rn over $175,000 after overh ead and befo re taxes.
Incentives fo r practic ing in underserved areas range fro m higher sa laries and hi gher fee-for-servi ce payments to loan forgiveness, lumpsum payments, increased continuing med ica l educa ti on, and ho liday suppo rt . M ost rural phys icians have low er overhead costs and the
oppo rtuni ty to earn higher income fo r performin g procedures that would otherwi se be ca rri ed out by other spec iali sts .
In the midst of Ca nada-wide and global sho rtages of fami ly phys icians, the Ca nadi an government is rea li zing that a robu st primary ca re
system is vital to the sustain abi li ty of our hea lth care system. Will you be the future of family medicine?

For more information please see http://www.cfpc.ca/whyfamilymedicine
This is a condensed v~ rsion of this ~oc ument. For the complete pamphlet with more detailed information, please send an email to
soms@cfpc.ca to rece1ve a full vers1on electronically.
Autho red by: lan Scott MD M Sc DO HS CCF P FRCPC FCFP (Vancouver, BC)
Go ldi s Chami BA BSc (Vancouver, BC)
Spec ial thanks to all of the medi ca l students who have contributed their feedback.
This article has been made poss ible through a financial contrib ution from Hea lth Ca nada . The views expressed herein do not necessa rily represent the
views of Hea lth Canada.
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Allin the Head
Pencilla Lang (Meds 2011)

I

n the middl e ages, a common treatment for fo reign bodies in the
throat was to ca ll upon St. Bla ise, the "defender of the throat":

"Piece of bone or thorn. whatever thou art, just as Jesus Christ
caused Lazarus to come forth from the tomb and Jonah from the belly
of the whale (here the patient should be eized by the throat) in the
name of St. Blaise, martyr and servant of Christ, 1 order three to
come up or go down" - Aetius of Amida (4th century AD) 1
Other early remedi es included th e use of th e dun g of lambs, th e
j ui ces of a snai l pi erced w ith a needl e, the as hes of burnt wa llow
mi xed w ith hay, or cent ipedes mi xed with pi geons' dung applied
externa ll y. 2
In G rade 5 I wrote a poem in which I described th e virtues and
draw backs of each medi ca l spec ialty. In it, oto laryngology held the
dou ble distincti on of being the mo t di ffic ult specialty to pronoun ce
and spe ll. Banis hed fro m my th oughts fo r th ese reasons, I gave
di eases of the ears, no e and throat little thought until I was
capti vated by th e compl exity and mystery of th e sphenoid bone in
medi ca l chool. Over centuries, th e stud y o f anatomy and phys io logy
have debunked many superstitions. We now know th at poisons
dropped into th e ear do not have th e same effect as poisons
swa llowed (as was be lieved durin g Shakespeare's time), and that
ting ling in th e left ear is not caused by our peers speaking poorl y of
us. Equa ll y many mysteri es remain . What causes allergic rhini tis
ra tes to ri se a nd fa ll a m o ng p o pul a ti o ns? W ha t is th e
pathoph ys io logy of mitochondrial hearing loss? Are minimall y
in vasive procedures an effective way to remove tumours with less
damage to surround ing tiss ues?

Despite th e changi ng landscape, th e UWOM J rema ins a
publi cation of wo rk written by and fo r UWO medi ca l and denta l
students. Our obj ectives are twofo ld : to edu cate and enlighten by
enco urag ing th e sharing of in fo rm ati on and idea between student ,
teachers and our medi ca l community, and to a ll ow UWO medi cal
students to ex perience th e process of craft ing their own research,
rev iew and case study arti cles. We in vite yo u to join us this yea r a
an author, suppo rter or reader.

REFERENCES
I. Ro ll eston, J. D. Laryngo logy and Fo lk-Lore. The Journal of Laryngo logy
& Otology. 1942;57( 12) : 527-532 .
2. Dani el CL, teva n CM. En cyc l op~tdia of uperst itions, Fo lklore, and the
Occu lt Sciences of the Worl d (Volu me I). Detroit: Ga le Resea rch Co;
1903 .

The study of ENT covers a vast spectrum of di seases and
crosses many medi cal spec ialtie , from wimmer's ears and sore
throats that frequ ent primary care offices, to problematic diffi cult
airways in anesthesia, and tumours vis ualized onl y through imag ing.
Thi s iss ue of th e UWOMJ is an eclecti c mi x of topics. We bring you
articles on the SoundBi te hearing aid that a ll ows a person to 'hear'
with the ir teeth, free-flap oromandibu lar reconstructi on tec hniques, a
new tra nsoral roboti c surgery procedure, the debate surroundin g
fund ing o f cochlear impl ants in Canada, and many more.
Since it 's establi shment in 1930, the UWOMJ has been
continua ll y changing and growing to meet th e needs of our
communi ty. I fi rst got in volved w ith th e VWOMJ as a j uni or
departmental editor in 2007, and over the yea rs I have had the
pri vi lege to w itness extraordinary growth in thi s j ourn al. Highli ghts
have incl uded th e forg ing of a partn ership w ith CU Adverti sing
all owing the printing and di stributi on o f th e UWO MJ free of charge
to readers, a beautiful new layout, a new online presence at http ://
www. uwomj .com/ (please do drop by and visit !), and the creation of
feature arti cle, departmenta l and artwork awa rds to recogni ze the
contributi ons of UWO medi cal students. The editori al team expects
the 2011-201 2 yea r to bring even more change - keep your eyes
peeled for an interacti ve online component to th e j ourn al!
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Microvascular free flap transfer for
reconstruction of oromandibular defects
Bre nnan Ballantyne {Meds 2014}, Sandeep Dhal iwal {Meds 2013}
Faculty Reviewer : Dr. Anthony Nichols, Department of Otolaryngology- Head and Neck Surgery, UWO

eco nstru cti on of the ma ndibl e prese nt unique cha ll enges to
th e head and neck su rgeon. A lthough mandibul ar defect ca n
resu lt from trauma, infection, congeni ta l defo rmiti es, or
osteo necros is, it most co mm onl y occ urs fo ll ow ing ablative surgery
fo r the treatment of benign o r malignant neoplasms. Primary intrabony mandibular carci no ma is rare; there fo re, th e in vo lvement of th e
lowe r jaw is usua ll y secondary to neoplas m ex tensio n from th e o ra l
cavity or the o rop harynx. A ltho ugh tum our resec ti on to ensure
patient surviva l is a surgeon's primary conce rn , not to be overl ooked
are aestheti c and quality of life parameters. The ma ndibl e serves to
prov ide shape for the lower third of the face, a borde r between the
face and neck, and po itions th e mentum and lowe r lip. Functionally,
it supports masticatory forces and the mandibu lar dentiti on as we ll as
the tong ue in both pos ition and function . On ave rage, it must su ta in
a force of 726 with a maximal force occurrin g at the molar teeth of
4346 N. 1

R

The use of nonvascu larized techniques for repa iring th e
mandible provides excell ent res ults in certai n pati ents. For exa mpl e,
allo pl asti c impl ants, such as th ose co mposed of tita nium , provide
rapid recon tru ctio n optio ns w itho ut the need for ha rvest ing
autoge nous free fl aps. However, th e di sadva ntage of this meth od is
the ri sk of pl ate fracture, pl ate extrus ion, and ex posure w ith
subseq ue nt infection . A ltern at ive ly, free tissue transfer provides
superior re ults in repai rin g mandibular defects in most ituati on as
an abdunda nce of literature is available to sugges t th at such
techniques impro ve patients' quality of li fe.2 ·3 Figures 1-4 outline th e
basic pr i ncip les of tum o ur resec ti o n a nd oro m a ndibul ar
recon !ruction . C urrentl y, there are seve ra l urgica l o pti o n ava ilable
for th e repai r of oro mandibul a r defect us ing mi crova cul a r free fl ap
methods.

FIB ULAR OSTEOCUTANEOUS FREE FLAP

°

SCAPULAR OSTEOCUTANEOUS FREE FLAP
The cap ul ar osteocutaneo us free fl ap ( OFF) is a ve rsa tile fl ap for
ma ndibul a r reconstruction as it enables repair of many bone defects
whil e imulta neou ly providing a n abundance of soft tiss ue for
repa iring defects that involve fac ia l ski n and o ra l mu cosa. The SOFF
can provide up to 14 em of ca pular bone, and is ba ed o n the
circumflex sca pular artery and vei n. 12 The bra nc hing pattern of th e
vascul ature permits harvesting a number of fasciocutaneous and
osteoc utaneo us flaps . Often, part of the lati s imus do rs i and/or
erratu ante ri o r va c ul ari zed by the thoracodorsal a rtery and ve in
ca n be inco rpo rated to provide mo re soft ti ssue bulk. Neverthe le ,
the limited length, wid th and integrity of bone ava ilable makes the
scapul ar fl ap un suitab le for denta l implants. Decrea ed range of
shoulder moti o n ca n occur if aggress ive post-o perati ve physical
therapy is not carri ed o ut. However, nea r no nna l function ca n be
obtai ned if proper rehabi litati o n i pursued. A drawback of the fl ap is
the n eed to change the positio n of th e pati ent durin g surgery fro m
upm e to latera l fo r harvestin g. Thi s prevents harvest of the flap at
th e sa me time as th e tumo r ablati o n, w hi c h may pro long th e case.

SCAPULAR TIP OSSEOUS FREE FLAP

The fibul ar free fl a p has been deemed th e " workh o rse" donor s ite for
reco nstru ctio n of oroma ndibul a r defec ts because o f it versa ti lity,
frequ ent use, and success rates th at approac h upwa rd s of 95%. 4-6 The
fibu lar fl ap i vascul arized by the peronea l artery a nd its two
assoc iated venae co mitantes. The e ntire fibul a (- 25cm) ca n be
harvested except for ma ll segments at th e di ta l and prox ima l ends
to prese rve joint stab ility and ca n be used w ith th e fl exor ha lluc is
lo ng us muscle or a sk in paddl e for additi o na l oft ti ssue repair.7 As
such, it is th e natura l choice when lo nger le ngths of bone are needed
to re pa ir a s urg ica l resec ti o n a nd a n exce ll e nt c ho ice for
reco nstructions that require primaril y bone or where th e ma ndibl e is
atrophi c.8 The fibu lar fl a p prov ide enough bone fo r supporting
dental impla ntati on an d is an idea l match fo r th e co nto ur of the
natura l j aw a nato my.
Criti c isms o f th e fibul a r free flap have surrounded th e he ig ht
di sc repancy com pared to th e nati ve mandible , and th e ina bility to

4

reco nstruct la rge-sca le so ft ti ssue defects (ie. those res ulting from
tota l g lo secto mi es) .
otwi thsta ndin g, continued innovation has
res ulted in the development of a " doubl e-barre l" tec hnique that folds
th e fibu la onto it e lf and the reby effecti ve ly doubles the height of the
mandibl e avai lable for osseo integrated implants. 9 Large soft ti ssue
defect ca n be re pa ired by u ing a second fl a p such a the radial
fo rearm free fl ap o r pectora l is myocutaneo us flap . 1 Finally donor
site morbidi ty is a pa rti cu lar co ncern . A ltho ug h most patients will
experi ence a hindrance in ankl e planta r- and do rs i-flexion range of
moti on and trength te tin g, tudies have hown that thi decrease is
not enough to impact patients' quality of life. 11

Preferred by the head and nec k tea m at the University of Western
Ontario, one increasing ly popular a lternative to the trad itiona l
sca pula r fl ap is th e sca pu la r tip osseous free fl a p based o n the angular
branch of th e thoracodorsal a rtery. Thi s modified fl ap enable the use
o f up to 20 em of bone, is often harvested with the lati s imus do rsi
and/o r . serratu anterio r muscles, a nd provides the optio n of
1 ~ crea _m g the kin a nd musc le pedicl e le ngth by a lso ex tending the
di ssecti on to th e subsca pular artery and ve in. Thi s a ll ows the pedi c le
~ength to reach upwards of I 7 em compared to 6 em from th e OFF.
3
Furthe rmore, th e tri a ngu_lar nature of th e infe rior a ng le o f the
scapu la a ll ow for harvest mg a grea ter va ri ety of 3-dime ns iona l
s ha pes: . These reco ns tru c tion adva nt ages - in creased bone
ava il abil ity, mcreased pedi c le le ngth , a nd bone geometry _ offered by
tl~e sca pula r tip free fl ap have been shown to be associated with
hi g hl y successfu l surg ica l outco mes .1 4
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ILIAC CREST OSTEOCUTANEOU FREE FLAP
The iliac crest osteocutaneou free fl ap (I OFF) offers unique
advantages ~ver th e fibul ar fl ap w ith re pect to quality and quantity
of bone ava ilable. The natura l shape of the ili ac crest resembles the
mandibl e anatomicall y, and th erefore minima l osteotomy is required
to form the neomand1ble. For exampl e, th e hemimandible can be
recreated from th e ip ilateral ilium using the anteri or superi or ili ac
pme to restore the mandibular ang le. 15 The avai lab le bone has a
height comparable to th e nat ive dentate mandibl e, and is th erefore an
optunal substrate for denta l implantat ion. However, th e surgery is
very complex compared to newer options, and has been largely
supplanted by the fibular free fl ap as the primary choice. The ICOFF
bl ood . uppl y is based upon deep c ircumflex iliac artery and vein 7
The mtem al oblique mu cle is thin and pliab le and can be
manoeuvred independentl y of the bone easi ly and reliab ly.I S A
s1gmficant draw bac k to the u e of th e ICO FF is th at harve t invol ve
the rel ease of the ~ bdomin a l muscles to access th e periton eal space
leadmg to morbidity at the donor site, inc luding issues of hemi a
preve ntiOn a t the abdominal wa ll , ga it a lte ration , se nso ry
disturbance , and ac ute pain . There fore, ignificant rehabilitation is
often req uired to rega in norma l ambul ati on.

RADIAL FOREARM FREE FLAP
The radi al forearm free fl ap (RFFF) has some of the best blood
suppl y compared to oth er tissue options, is we ll innervated fo r good
recovery of sensory function , and additional bulk can be added by
mcorporatmg the brachioradiali s musc le. 7 The arterial supply to th e
RFFF IS ba ed on the radial artery. There fore, an Allen test must be
performed before harvesting thi s flap to ensure th e ulnar artery can
adeq uate ly. upply the hand. Venou drainage occurs through th e
venae com1tantes of the radial artery or via th e cephalic vein .
. T~ e .RFFF o~ers a large area, thin and pliable skin segment
which IS Ideal . for mtra-oral reconstruction thu making it the most
~1de l y u ed microvasc ular free flap in all head and neck surgery.I 6 It
IS used more for defects of the oral cavity, oropharynx, nasopharynx ,
and tongue as a fasciocutaneous flap , but the option of using it as an
osteocutaneous fl ap by including bone is available. I6 Approximately
I 0 em of bone can be taken . A lthough it is strong cortica l bone, it
tends not to be very thick as on ly 113 of the cro -sectional area of
the radial bone can be taken without increasing the ri sk of stress
fracture to the arm . As such, RFFF is best suited for latera l or ramus
mandibular defects that require minimal amounts of bone but an
abundance of so ft tissue. Known limitations include the lack of
availab le bone for osteotomy, and morbidity at the donor site due to
the bulk of remaining bone . Fracture rate foll ow ing RFFF
approaches 18% of cases, 17 but prophy lactic intemal fi xation of the
radius has been shown to reduce thi s fracture rate to as low as 4.5%.
18 Tapering edges of graft in a " boat tail" can also reduce the risk of
postoperative fractures as can a prolonged period of immobilization
(3 weeks). 8 For these reasons, on ly small bony defects of th e
mandible are repaired using radial forearm flap, or it is combined
with other donor sites (ie. iliac, fibular or scapu lar). 19

POST-OP I OUTCOMES I COMPLICATIONS
Success rates for free tissue transfer at most hi gh volume centers is
high, exceeding 95% or higher. 1·10 However, close postoperative
monit_oring can detect complications that may affect ti ss ue viability,
allowmg for early intervention to minimize recipient site morbidity.
The most common complications that threaten the viabi lity of the
free flap results from vessel thrombosis, predominantly in the veins.
20 Hematomas as a result of the surgery or the failure to place an
adequate suction drain are also well-known complications. Other
problems that have been cited in the literature as causes of morbidity
include pulmonary problems, prolonged ventilatory support, and
acute alcohol withdrawaJ.I 9

Postoperati vely, most pat ients are transferred to the intensive
care unit fo r an average of 2.44 days, and an average ho pita! stay of
2-4 weeks.21 The most common method of monitorin g the graft
includes assess ment of flap co lour, pin prick and bleeding rate,
capi ll ary refill , ski n surface temperature, and Doppler igna l
investi ga ti ons. Other methods less commonl y used are e lectri ca l
impedan ce pl ethysmography, Ia er Doppler, photopleth y mography,
tran cutaneous pulse oximetry, and scintigrap hy20
. Pat ient are fo ll owed long term to ens ure that the flap remain
VIable, the aesth eti c goals of th e patient have been reached, and th at
the patient is achieving fu nctiona l rehabilitation . A 10 year fo llow up
of these patients has revea led that aest heti c outcomes are achi eved in
90% of patients, 70% have regular diets and the remainder have soft
di ets, 85% have easil y intell igible speech, and greater than 90% have
preserved bone height, indi cating that th ere is minimal bone
re orpti on 22 These re ults hi ghlight the notion th at microvascul ar
free fl ap reconstru cti on has ac hi eved excell ent o utcome th at are
ce lebrated by health care teams and their pat ients.

FUTURE DIRECTIONS I CONCLUSION
Head and neck reconstructi ve urgery has seen monumenta l adva nces
in the past few decade . State-of-th e-art microva cular equi pment,
along w1th the de velopment of numerou free flap ti ssue opti ons ha
res ulted in vasc ul ari zed osseou free fl ap transfer becoming th e
preferred meth od for reconstruction leadi ng to a dramati c rise in
rep~i: ucce
rate.23 Currentl y, in th e field of oromandibular repai r,
excit.mg new advances are continuall y being made to improve
surg ica l outcomes . For exa mple, th e co nce pt of di trac tion
osteogenesis, originally deve loped for orthopedi c appli cati on to
l e ~ gth e n bone, is b eg i~n~n g to be used by head and neck surgeons.
Di stractiOn osteogenesis mvolves an extemal mechani ca l device that
se parates two bony surfaces. The length of the di straction is th en
progressive ly lengthened over everal days to a llow a gap for new
bone to form durin g th e consolidation phase. It is used for patients
With poor functiOnal outcome followin g reconstructi on due to scar
fonnation or inadequate bone length 8 · 12 Moreover, the fi e ld of ti ssue
eng ineering also holds promi se for the future of head and neck repair.
The use of recombmant bone morphogenic protein (rhBMP-2) has
been shown to stimulate bone regenerati on without the use o f
autologous grafts in an in vitro setting. 24 Additional ly, in vivo animal
and cadave~ic studies have demonstrated the utility of ti ssue
eng m ~enng m developmg bone grafts for the use of reconstructing
mand.Ibular defects.25 ·26 In thi s manner, th e deve lopment of
techniques that allow for the transfer of cultured cell substrate to
regenerate portions of the mandible w ill likely offer the next step in
th e evolution of mandibular reconstruction .
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b !ruction of the centra l airways, the trachea and main stem
bronchi, may result from many disease processes including
malignant growth . It is estimated that in the United States,
malignant neoplasms will cause centra l airway obstruction (CAO) in
80,000 cancer patients a year. 1 lt is estimated that 20% of these
patients wi ll experi ence ignificant morbidity due to per i tent
cough, dyspnea, and obstructive pneumonia, and as many as 35-40%
of lung cancer patients die due to complications resulting from locoregional di sease. 1•2 While most treatments for malignant CAO are not
curati ve, they have been shown to improve resp iratory function ,
avo id mortality, and improve quality of life.3.4. 5•6 Many different
strategies for managing malignant airways exist. Choosing the best
one depends on patient factors such as presence of co-morbidities,
medical stability, the nature of the underlyin g tumour, and overall
prognosis. Non-patient related factors such as ex pertise of medical
staff and avai lab ility of technology also greatly impact the mode of
treatment chosen.2 This article presents current treatment options for
malignant CAO, spec ificall y, therapeutic bronchoscopy, radi otherapy,
and surgical resection .

O

CAUSES OF MALIGNANT CENTRAL AIRWAY
OBSTRUCTION
The most common mali gna nt causes of central a irway obstructions
are direct extension into the airway lumen by extrinsic tumours (fig.
lb).2 Of these tumours the most common types are bronchogeni c
carcinomas (i.e. small cell lung cancer and non-small cell lung
cancer), fo llowed by esophageal and thyroid carcinomas 2 Primary
tumours of the trachea and bronchi , or intrinsic central airway
tumours (fig. Ia) are re latively rare. Seventy to eighty percent of
these tumours are of squamous cell or adeno id cystic carcinoma type.
2 Squamous cell carcinomas typically occur later in life and more
frequently in men and smokers, while adenoid cystic carcinomas are
found in younger patients and are not related to exposure to smoking
Occasionally, but less frequent ly,
or to the sex of the patient 3
metastases from carcinomas of the breasts, kidn eys, co lon, th yroid
and esophagus may spread to the respiratory system and cause CAO .

frequently, pneumonia . 1.3· 7 Because the e ymptoms overlap with
those found in asthma and COPO, patients with malignant CAO are
common ly misdiagnosed . However, a trong indi cation that
symptoms are due to CAO is that they are unresponsive to inhaled
steroids and bronchodialators . Other advanced CAO ymptoms are
related to si gn of decreased ventilation such as tachycardia,
diaphore is and increased work of breathing.7•8 Symptoms of
bradycardia, cyanosi s and obtu ndation suggest that the airway lumen
is severe ly compromised and in need of immediate interventi on in
order to avo id imminent respiratory fa ilure.7
Evaluation and diagnosi s of malignant airways is often based on
clini ca l exami nations as well as a tissue biopsy and radiological
studi es to confirm the diagnosis 2 While chest radiograph s have little
di agnostic va lue, they may be used to quickly rule out other causes of
breathing difficul ty such as tracheal deviations or a pneumothorax .2 ·3
Che t and neck computed tomography (CT) scans make it possible to
estimate tumour size, depth of in vasion, and the ability to see if the
airway di stal to obstru ction is still patent, providing important
infonnati on for treatment planning.2.3 CT sca ns are typically always
performed in conjunction with bronchoscopy, the go ld standard for
eva luati ng CAO . Bronchoscopy allows for direct visualization of the
tumour, eva luation of tumour length and locati on, differentiation
between an intrinsic endobronchi al and ex trin ic tumours, and most
importantly, is equipped to prov ide a tissue dia gnosis 2 •3 Moreover, if
needed, di agno tic bronchoscopy may be quickly converted to
therapeutic bronchoscopy for CAO management.

a

b

2. 7

CLINICAL MANIFESTATIONS AND DIAGNOSIS
Clinical manifestations of malignant CAO depend on size, location ,
and the rate of progress ion of airway obstruction . Moreover, the
patient 's underlying health status and ability to compensate for
decreased airflow will influence the extent to which symptoms
appear. 1·2 If encroachment into the airway is minor, then there wi ll be
little impact on airflow and patients wi ll likely be asymptomatic and
never brought to clinical attention . The majority of patients that
experience symptoms of CAO have advanced disease and a hi story
of underlying malignancy. 7•8 Thus, symptoms of CAO are late
findings and include dyspnea, cough , wheezing, stridor and

Figure 1: Schematic diagram of 1ntnnsic (a) and extrinsic (b) tumour
obstruction of the central a11ways. Each demonstrates 50% occlusion.
Adapted from BeDinger et al. Therapeutic bronchoscopy w fth immediate effect:
laser, electrocautery, argon plasma coagulation and stents (2006) .
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TREATMENT MODALITIES

v) Airway stent insertion:

I) Therapeutic bronchoscopy:

Airway stents are made of s ilicone, metal or a combination of both
and are u ed to mechanically prop open obstructed airways. Stents
restore airway patency, improve ventilation, and allow for the
c learance of airway secretions.2•7·8 They can be used as standalone
treatm ent or in conjunction with debulking and they do not interfere
with
ub se qu e nt radiation treatments , brachytherapy, or
chemothe rapy if an y are needed.8 Moreover, if the patient's
ventilation tatu improve followin g treatment, silicon stents can be
removed.2 However, metal stents are very difficult to extract and are
essentiall y perm ane nt. 2· s One of the greatest advantages to using
tents is that th ey may counteract compression by tumours extrinsic
to th e a irway. Compli cati o n include ste nt migration , more
co mm onl y ee n w ith ili co n ste nts, and stent obstruction by recurrent
tum our growth or granul ati o n ti ss ue formation (typica lly seen with
ewe r meta l tents used for malignant airway
metal stent ).2.8
obstructi o n have s ilicon covering and are made ofNitinol , a flexible
e la ti c bio mate ri al, to he lp avo id stent obstruction .2 Additionall y,
newe r silicone ste nt are mes hed for fl exibili ty a nd haped or tudded
to prevent te nt mi g rati on2
Indicati o ns fo r th erapeuti c bronchosco py are the pre ence of
ymptoms of adva nced CAO .
ec ros is, bleeding and cartilaginous
destru cti on a re not contra indicati ons fo r treatment. 8 In emergency
settin gs, therapeuti c bro ncho co py may provide more immediate
improvement of th e pati ent 's ventilato r statu and tabili ze them
enough fo r furth er treatm ent w ith radi ati o n o r c hemotherapy.s
Drawbac ks to th e use of a ri g id bronchoscope are that it require
pati e nts to be und e r ge ne ra l a naes thetic . Thu s, therapeutic
bro nc hosco py, balloo n bro nchoplasty withstandin g, ca n only be used
in pati ent th at have e nough remaining respirato ry capacity to
to lerate edati on.

Th e rap e uti c bro nc hosco py utili zes th e ri g id sta inl ess s tee l
bronc hoscope to visua lize, treat and debulk tumours. Its wider
diameter fa cilitates ventilati o n allowin g for a va ri ety of procedures to
be perform ed, including tum our debulkin g, laser resecti on, argonpia ma e lec trocoagul ati on, ba lloo n broncho co py, and stent insertion
to re-cannuli e th e a irway2. 7,

i) Tumour debulking:
The harp bevelled tip of th e ri g id bronchoscope is u ed to co re out
th e tumour and appl y press ure to a irway wa ll s promotin g clot
fo m1ati on. However, inadvertent damage to urro unding airways
durin g trea tm ent is a ris k and complicati ons may include cutt ing th e
lips, g um , larynx or a irway mu co a or cartil age du ring intubati on.
Perfo rati on o f the medi a tinum may a lso occ ur if the scope is not in
line w ith th e airway lumen 8
ii) Laser Resection:
Laser energy de li vered by optical fibre is used to resect obstructing
tumo ur . The ma in type of Ia er u ed durin g bronc hoscopic resecti on
is th e eody nium :yttrium a luminum garn et (Nd :YAG) lase r w hi ch
transmit light energy at I ,064 nm wave length to the ta rget tis ues 2 ,7
The therma l energy from th e Nd-YAG lase r i abso rbed into th e co re
of ti sue where temperature may reac h up to 100°C 2 The heat is
then tran mitted and cattered a ro und into surrounding tiss ues o th at
tota l ti ssue effects may ex tend up to I Omm be low the surface o f laser
admini strati on.2.7· 8 Darker pigments, such as those found in blood
max ima ll y abso rb energy from Nd- YAG lase rs. As a result, ti ss ues
ex posed to th e laser energy are devasc ul ari zed- a process otherwi se
known as e lectrocoag ul ati o n 7 Additi ona l admini strati on of the NdYAG Ia e r ca u es charring and eve ntua l va po ri zati on, whi ch is
removed by ve ntilation from the bronc hosco pe.2. If tiss ue is not
co mpl etely vapori zed, it may be mec hani ca ll y debulked. Beca use
tota l ti ss ue e ffects are not immedi ate ly visible durin g trea tm ent and
may ex te nd we ll past th e depth of the tumo ur, compli cati ons include
late devascul arisati on of adjacent healthy ti ssues we ll afte r th e
treatm ent i co mpleted.2.s

Radi ati on ha long bee n used to decrease tum o ur s ize and improve
sy mpto m th ~ t res ult fro m a la rge tum our burden, espec ia ll y in
palli all ve settm gs. For ma lignant CAO , radi ati on may be delivered in
one of two meth od : intrins ic rad iati o n treatme nt (i.e. brachytherapy)
or ex te rna l bea m rad io the rapy (E BRT).

i) Brachytherapy:

iii) Argon-Plasma Electrocoagulation:
A rgo n- Pl as ma Elec trocoagul ati on (A PE), as o pposed to lase r
e lectrocoagul ati on, i a form of no n-co ntact e lectrocoagul ati on.
s111g a 5,000-6,000 vo lt park at the ti p of th e pro be, argo n gas, a lso
re lea ed at the ti p, become an ioni zed plas ma th at find th e nea rest
gro unded tissues produci ng coagul ati ve necros is. 1 Adva ntage of
A PC a re th at it may trea t tum o urs latera l to or aro und a co rner fro m
th e tip of th e probe that wo uld not oth erw i e be access ibl e fo r laser
the rapy. 1·9 T he e lectro n energy utili zed by A PC, however, doe not
penetrate ti sue as deepl y as Ia e r ene rgy res ulting onl y in
uperfi cial nec ros is o pposed to th e dee p ti ue necros i crea ted by
Nd-YAG laser .9 This may be des irable fo r trea ting superfi cial
squamo us ce ll carcinom as o r if majo r bl ood vesse ls are close to th e
tum o ur bed.9

iv) Balloon Bronchoplasty:
Ba lloo n bro nchoplasty u es a ba ll oo n to eve nl y dil ate th e airway with
m1mm al tra um a a nd ub eque nt granul ati on tiss ue fonn ati o n in
mucosa l ti ss ues. :While most ri g id bronchoscope techniqu es require
genera l anae theti c, ba ll oo n bronc hopl asty may be perfonn ed with a
fl ex 1bl e bro nc hosco pe und e r co nsc io us sedati o n. 1 Dilati o n is
immedi ate ly e ffecti ve a nd may be used for both intrin ic a nd
ex trin ic airway ob tru c.ti on . The re ults o f ba lloo n bronc hopl a ty
are ~ o t typicall y s u s ta ~ne d and dil ati on is usua ll y followed by
stent111 g ?r lase r resectiOn . o mpli cation inc lude airwa y rupture
res ult111g 111 pneum oth o rax , medi astinitis and bl eedin g. I

8

2) Radiation Treatment:

Brachyt he rapy re fe r to the place ment of a radi ati o n o urce within or
adj acent to th e ~i ue . be ing treated . Thi s is achieved by plac ing
~a dJ a t1 on eeds d Jre.c tl y mto the tumo ur (interstiti a l brachytherapy) o r
111 e~lin g cath eter 1nto the lumen of the orga n be ing treated suc h a
~ n a1rway. For th e trea tm ent of ma lignant C AO, a n e mpty catheter is
1n erted 111to lumen o f th e a irway approx imatel y two centime tre
beyo nd th e e tim ated di ta l end o f a target area th at includes the
tum o ur.2 The cathete r is the n sec ured at th e nostril and a radi ation
~urce, most co mm onl y iridiu~11 -l 92 , is then loaded into the catheter.
2
· The area ta rge ted by ~ad1 a tJ o n ca n be several centimetre long
dependin g on w heth er h1 gh-do e radiation (HDR) or low-do e
radi ati.o n ( LOR) is u ed .2 However, LOR has fallen out of favour and
HDR IS mo t c mmonl y. used as it utili zes the g reatest advantage of
th e brac.hytherapy tec.hn1que, ~h ~t 1. , th e radiation delivered directly
at the 1te o f ta rget t1 . sues minimi zes radiation expo ure to nearby
hea lth y o rga n oth erw1 e ex posed during external beam radiotherapy.
In th1 s way HDR brac hytherapy exposes vital tructure near the
airway- such a th e esophagus, thyroid, mediastinum and aorta- to
11111111nal ~mounts of radiation while enabling larger radiation do es
·
dto 1·be de li vered . to th e target ti s ue ites · A typ 1' cal HDR reg1men
e Ive rs a fra ction dose of 7,000-8,000 cG y admini stered once a
wee ~ fo r three. week ; however, the exact dose a nd number of
fractJ.o ns (rad~a t1on treatment ) will de pend on the ize of the tumour
and 1~s locat1on .2·8 Each fraction lasts between 3 to 30 minutes
a llowmg brachythe rapy to be delivered a
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an outpati ent procedure. Brachyt herapy is contraindi cated for
tumours that invade major arteries or other tructures within the
medi astinum 8 Compli cations include earl y and late radiation effects
uch a radi ation bronchitis, hemoptys is, bronchial stenosis, and
bronchia l fistu las 8
ii) External beam radiotherapy:
Extern al beam radi otherapy (EBRT) has va riable efficacy for treatin g
CAO and the therapeutic effects may be quite delayed. However,
EBRT continues to be a ma instay of treatment for CAO especia ll y in
patients wi th hi ghl y adva nced di sease or comorbiditi e that preclude
them from undergoing general anaesthetic. Palliati ve doses of EBRT
for the treatment of CAO are typica ll y 3,000 cGy in I 0 consecuti ve
fractions . Side-effects a lso include earl y and late radiation effects.
Early effect are radiation dermatiti s to the overl ying skin and
fatigue . Long-tenn effects mai nl y invo lve thoracic stru ctures close to
the airway ( uch as the lungs), whi ch may undergo fibrosis as a result
of inadvertent radi ation ex posure. However, current techniques in
EBRT such as intensity-modulated radiation therapy in conj unction
with shielding or stereotactic body radi otherapy effectively minimize
radi ation ex posure to surrounding ti ssue .

3) Surgical resection:
Surgical resection is usuall y reserved for tracheal tumours that have
not yet metastasized to other areas of the body. If surg ica l resection
is successful at removing the entire tumour and achieving negati ve
margins, it may be a curative treatment for cancer. The procedure
involves removal of the tumour and the in volved trachea l segment
followed by re-anastomosis or reconstruction of the trachea l tube. 3
Tumours that involve the carina or subglottic larynx can be
successfully resected while preserving ventilation and voca l
functioning .3 In addition, it is possibl e to remove up to 50% of the
cervical or intrathoracic tracheal length without compromi sing
anastomotic hea ling.2.3 While its adva ntage is that it is a potentially
curati ve treatment fo r cancer, surg ica l resecti on cann ot be
perform ed if complete tumour removal threatens the hea ling of the
anastomosis, if the tumour length exceeds 50% of the trachea or if
vi tal structures such as the aorta or heart are involved.3 Moreover,
the presence of CAO symptoms that alert clini cians to the need for
treatment typica ll y appear at adva nced stages of di sease when
metastati c spread has likely to have already occurred . Although
surgical resection cannot be performed after the mediastinum has
received a hi gh-do e of radiation (due to impaired ti ssue healing), it
may be followed by adjuvant radiation therapy to decrease the
likelihood of loco-regional disease reoccurrence.

DISCUSSION
Interventions for mali gnant CAO are highl y technical and require a
large amount of medi cal resources and teams of well-tra ined
medical personneJ.2 Often the widespread ava il ability of these
treatments is limited to patients within a reasonable di stance of
specialized center . However, many studi es have shown that these
treatments are effecti ve, improve patient quality of life, and may be
life-saving in emergent situations. 3.4·5·6 In a prospecti ve cohort
study of 20 patients with symptomatic CAO , a ll pati ent
demonstrated improvements in airway diameter and 16 patients
achieved greater than 80% patency using therapeutic bronchoscope
techniques 4 Moreover, the study demonstrated that Nd:YAG laser
therapy alone, airway stenting alone, and a combination of stenting,
laser, and/or cryotherapy were each indi vidually effecti ve at reestablishing airway patency and improving symptoms. 4 Si milar
positive results were demonstrated for the treatment of CAO usi ng
stent insertion and radiotherapy. Authors of a multi center tri al
found that silicone mesh, studded stents re-established patency, and
improved fun cti onal capacity, dyspnea, and g lobal functionin g at I
month and 3 months after stent placement. 5 HDR brachytherapy

has also been fou nd to be successfu l in prospective cohort studi e
at improvi ng symptom of CAO by more than 90% 6 Lastly, for
patients e lig ible fo r surgical resection, surgery offers a high rate of
curative uccess J Whil e most of these tri al compared intervention
to no treatment and were not randomi zed contro l trials, they have
demonstrated that interventi on may improve symptom and
quali ty o f li fe . However, to date there are no best practi ce
guidelines avai lable on which interventi ons should be used. It has
been frequentl y observed that the best approach includes a
combinati on of treatment interventi ons 2, and a lthough man y centers
are already uti li zing these interventions to manage ma lignant CAO,
cho ice of treatment is heterogeneo us and centre-speci fi c.
As incidences of ca ncer and specifical ly bro nchogeni c
tumour continue to ri se, it can onl y be ex pected that a growi ng
number of patients wi ll need to be managed for mali gnant CAO.
Sign and symptoms of malignant CAO occur at adva nced stages
of disease and patients sufferin g from CAO almost a lways have a
positive hi story for underl ying ma li gna ncy. Symptoms of CAO
may be treated with a number of techniques including therapeuti c
bronchoscopy, radi otherapy, or surgical resection . Each modality
has been shown to improve symptomo logy, decrease morbidity, and
improve quali ty of life. There are currentl y no best practice
guidelines for managing ma li gnant CA O. While patient fac tors will
contribute to the dec ision mak ing process, the cho ice of
interventi on may be most determined by centre reso urces and
ava ilab ili ty o f skilled personnel.
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Listening with our teeth! The SoundBite
Hearing Aid: a new technology for single-sided
deafness
Melissa J. MacPherson (Meds 2014), Mayoorendra Ravichandiran (Meds 2013)
Faculty Reviewer : Dr. Lorne Parnes, MD (Department of Otolaryngology)

earing loss is a significant and common disa bility that affects
Thi s
approx imately 9% of the Canadi an populati on.'
di sabili ty is more preva lent in older populati ons2 and if
uncorrected can lead to soc ial iso lati on and communi cati on
diffi culties 2 · 3 There are two distinct types of hearin g loss; each with
a characteri sti c pathophy io logy. Sensorineural hearin g lo (SNHL)
arises fro m conditions affecting th e inner ear or the cochlear nerve,
whereas conducti ve hearin g lo s develops from conditi ons a ffecting
th e outer ear, the middle ear and the tympanic membrane. These
di tincti ons are important since hearing aid technologies address the
di ffe rent types of hearin g loss using different strategies . Patients
with a conducti ve hearin g los require the amplification o f all so und
wave frequencies.2•3 In contrast, pati ents affected by sensorineural
hearing loss present a much more complicated technological problem
since these patients may have decreased audibility of certain so und
fre quencies as oppo ed to an overall decrease in the audibili ty of all
sound frequencies 2 Most pati ents w ith sensorineural hearing loss
have decreased audibility of hi gh frequencies;2 however, in the case
o f Meniere 's di sease there is a decreased audibili ty of lo w
frequ encies.4 This res ults in th e ability to hear so und but the inability
to understand speech since speech amplitude (loudness) is caused by
low frequency so und waves which the patient can detect but speech
comprehension is poor due to th e loss in detecti on of th e hi gh
frequ ency sound wa ve components.2 Speech comprehension is more
diffi cult in th e presence o f background noi e and consequentl y
hearing aid technologies address thi s iss ue by increas ing the signalto-noise rati o to bring out speech from no ise.2

H

HEARING AID TECHNOLOG I ES FOR UN I LATERAL
SENSORINEURAL HEARING LOSS
Patients with unilateral sensorin eural hea rin g loss ( ingle-s ided
deafness) also face diffi culti es loca liz ing th e direction o f unseen
so unds and detectin g so und loca li zing from th e directi on o f th e
affected ear, in addition to the diffi culti es previously mentioned.s
The head shadow e ffect cause a parti cular diffi culty for these
patients since so und waves ori g inating fro m th e affected ide are
attenuated by th e head before reaching th e fun cti onal ea r. Several
technologica l strategies used to address some of th ese problems
include th e routin g of sound from th e di sabl ed ear to th e full y
fun cti onal ear using air conducti on contralateral routin g o f so und
(C ROS) dev ices or bone-anchored hearing aids (BAHA).2.5
While CROS devices do not allow for so und loca lizati on, they
do aid a pati ent to overcome the head shadow e ffect. CRO devices
consist of essenti ally two hearing aids. One hearin g aid ac ts as a
microphone in th e affected ear and transmits the auditory ignal to a
second hearin g aid th at acts as a receiver in th e fun cti ona l ear. The
C ROS hearing aid in current use are wire less devices th at u e FM or
Bluetooth technology to transmit th e auditory signal to th e extern al
rece iver.2
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BAHA devices take advantage of the ph ys ical property of bone
to conduct ound . The first BAHA device was developed by a
Swedi sh anatomi st, Per-ln gvar Branemark, and impl anted in three
pati ents in 1977. The dev ice has achieved international recognition
as a solutio n to conducti ve hearing loss w ith more than 80 000
device currentl y in use worldw ide 6 The device also has a second
applicati on fo r th e treatment of unilatera l sensorineura l hearing loss. 5
The BAHA system consists of three components: a titanium post
implant, an external abutment and an e lectronic sound processor. It
is important to note th at th e BA HA ystem requires surgical
implantati on of the titanium post fo ll owed by th e integration of the
implant into th e bony architecture. The device wo rks by transmitting
sound thro ugh bone to the inner ear thus, skipping both the external
In the case of unil ateral
auditory canal and the middle ear.2·5
sensorineural hearin g loss the sound is transmitted transcraniall y and
stimulates th e cochlear fluid of the unaffected inner ear.
The
titanium screw is implanted directl y into th e masto id bone in order to
overcome th e lo s o f energy during the transcutaneous transmi ssion
of sound . The electronic so und processor is responsible for the
transmi sion of ound vibrati ons via the externa l abutment to the
titanium implant. 7 Despite its value and populari ty, there are a
number o f complicati ons a sociated w ith th e BAHA device. The
most common complicati on is skin irritation at the site of the
implant. 7•8 In most ca e , thi s can be managed using topical therapy.
A more seri ous complication is the failure of th e titanium post to
osseointegrate.7•8 Thi complicati on can lead to poor function or
failure of the implant.
In addition, several less common but
potentiall y dangerous compli cati ons such as kin flap necrosis,
wound dehi scence, bleeding and pain have been reported 8 The
so und conducti on property of bone ex plo ited in the BAHA
technology has also been applied in the most recent technological
adva ncement for the treatment o f unilatera l sensorineural hearin g
lo ; the SoundBite Hearin g Aid .
THE SOUNDBITE HEAR ING AID

A unique technologica l approach for the treatment of unilateral
sen orin eural hearing loss is the use of a removable ora l device
called the SoundBite hearin g system developed by Sonitus Medica l.
The SoundBite hearing system also makes u e of the ound
conducti on properti es o f bone; yet, unlike th e BAHA system does
not require the use of surgery.3•9 The SoundBite hearing system uses
a mi croph one unit housing a receive r and wire less transmitter to
receive so und . The mi crophone portion of th e unit its in the affected
ear canal to take advantage of the ability of the ear 's pinna and
ext~rnal ear canal to capture and direct sound into the microphone,
whil e the rece1ver and the transmitter sit in a unit behind the affected
3 9
ear • The unit then transmits the captured ound wirelessly to a
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remova ble oral device similar to a retainer th at sits over the max illary
mo lars in th e mouth. The oral device touches several stru ctures in
the mouth including the gi ng iva, teeth and the inner cheek. The
electri cal signal from the behind the ear transmitter i captured by th e
ora l device and is transduced into vibrati onal energy usi ng a
piezoelectri c transducer.9 The vibrati on are conducted by way of the
teeth to the bone and transcrani a lly to the cochlea of th e ear. One of
the adva ntage of the piezoe lectri c transd ucer is that it allows a much
wider frequency range to be conducted thro ugh the teeth than the
traditional e lectrodynami c transducers used in th e BAHA systems.9
The oral dev ice does not require th e mod ifi cati on of th e
max illary mo lars and i custom fitted for each pati ent by taki ng a
denta l imprint of the max illary arc h.3 Si nce th e device vibrate the
max illary molars to trans mit v ibrat ions to the bone, the fo rce of the
ora l dev ice wa te ted to detem1ine if it wea rs th e teeth .
Interesting ly, the force of the oral dev ice is four ord ers of magnitude
lower than the force exerted on the teeth by nonna l masti cation and
is w ithin the force range of nom1al orth odontic devices and does not
damage the surface of the max ill ary mo lars.9 Moreover, the ora l
device is comfortabl e, we ll to lerated in most pat ients, does not affect
the speech and can even be worn whi le eating.3·9 There are several
adva ntages of th e SoundBite hearin g system which are outlined in
Box l . The most strikin g advantage of the SoundBite hearing sy tem
when compared to bone anchored hearing aid (BAHA) i the
avo idance of surgery 9 A patient can be fitted qui ckly for th e oral
device and begin using th e hearing aid immediately. With BAHA ,
The surgery is
surgery is required to imp lant a titanium post.
followed by 3 months of healing to ensure osseointegrati on of the
The
implant before th e pati ent can begin to use th e device 2
SoundBite hearin g system avo ids this dela y and avo ids potenti al
The
surgical complications seen with th e BAHA procedure.
SoundBite hear ing y tem is a tru ly unique and nove l technologica l
approach to address unilateral sensorineural hearing loss. The next
time you ee a patient with unil ateral sensorin eural hearing loss, take
a look in th eir mouth and chew on thi s possibility; they mi ght be
li stening through their teeth!

Box 1: Advantages and Disadvantages of the Sound Bite
Hearing System
Advantages

Avo idance of surgery and su rg ica l
complications
No need t o wait 3 month s befo re use since
osseointegration is not required
Di screet oral device and discreet behind th e ear
unit
Opti mized microphone locati on
Del ivers high-fidelity sound w ith a w ide
f requency range
Removab le devices
Disadvantages

Cannot drink alcohol wh ile wearing the oral
device
Ri sk of aspiration of the ora l device if the
patient' s physical responses are impaired
Risk of swallowing the oral device if the
patient's physical respon ses are impa ired
Healthy teeth are needed to fit the device
properly and good oral anatomy for full benefit;
the last 3 teeth in the maxillary arch are usually
the abutment teeth and must be free of active
caries, periodontal and endodontic conditions
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I

s de. afness a disease? Is it even a disability? Can or should it be
"cured"?

Such questions have been the root of many debates ove r the
nature of deaf c ulture since the advent of cochl ear implantati on in the
late 1950s. As implants become more re liab le and provide increasing
quality of hea ring to profound ly deaf childre n and adults, many in the
deaf co mmunity have grown to view implantati on as a threat to both
the ir way of life and the integrity of the communi ty. As a res ult,
factions of deaf society have waged a war aga inst cochlea r impl ants.
" I would be remiss not to eq uate cochl ea r implants with genocide"
stated a 1992 deaf position arti c le. 1
While suc h quotati ons represent an extrem i t view in the
communi ty, widespread concern s that coc hl ear imp lantati on would
diminish the deaf co mmuni ty 's size and cohesiveness, and that
cochl ear impl antati on represents a desire by th e hearin g popul ation to
" cu re" deafness exi ted we ll into the 1990 .2 M any in th e deaf
community fear that coc hl ear implants would res ult in decreased
resource ava il ab il ty and acco mm odations for the deaf, and hence
pose a threat to deaf culture.
For the purpose of this artic le, deaf culture ca n be characteri zed
as a co mmuni ty largely composed of pro fo undl y deaf indi viduals that
views deafness as a difference rathe r th a n a disability 2 They
characteri ze lack of hearin g as "deafhood" rather than "deafness",
with so me in th e co mmuni ty going as far as ca lling deafness a
" birthri ght of si le nce". 3 This comm unity provides reso urces,
ed ucation and training to its deaf members, a llowing them to
function within th e deaf co mmunity (i.e. through sig n language) and
in th e hea rin g world (i.e. throug h lip read ing). If one were to co nsider
implantation to be a treatment for profound deafness, most of those
impl anted at a yo un g age are like ly to not partake in th e deaf
communi ty as th ey wo uld now be integrated into ma instrea m
edu cati on.4
As ev ide nce mo unts in favour of coc hlea r impl antat ion, a shift
has been see n to a po int where th e vast majority o r e lig ib le c hi ldren
are implanted, parti cularly if born to hearing parents. In response to
th e grow ing prevalence of impl antati on, in 2007, th e Ca nadi an
Association of th e Deaf (CA D) re leased a positio n paper o n coc hlea r
implantation . They asserted th at whi le the CA D has litt le co ncern
abo ut autono mous adult imp lantati on, they do not be lieve emp iri ca l
research has provided suffi c ient evidence for the effi cacy of cochlea r
implants in supporting first-language acqui s iti on in deaf chi ldre n,
who a re un abl e to ma ke the cho ice for themse lves. 5 As th e body of
scientific literature in the field overwh e lmin g ly supports early
chi ldh ood imp la ntat ion, the CAD 's pos iti on appea rs to foc us on th e
ri ght of every deaf child to lea rn sign language, regard less of whether
th ey received an impla nt, allowing th em to grow up " bil ing ual and
bicultura l". It is diffi cult however to assert w hethe r thi s po iti on
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refl ects an effort by the CAD to mitigate th e loss of deaf cu lture by
trying to increase the involvement of implanted children in the deaf
communi ty.

THE RI GHT TO CHOOSE: WHEN TO I MPLANT?
With new born hearing screening program offered in eight provinces
an d three territo ri es as of 2008 , childre n with s ig nifica nt hearing
deficiencies are identifi ed earli er than eve r6 Therefore, armed with
an early diagnosis, parents are dri ven to mak e a decision regarding
cochl ear implantatio n in e ligible c hildren earli er in th e c hild 's life,
with a n increasing body of evidence indi cating s ig nifi cant advantages
to earl y im pl antation . otabl y, implantation in childre n under two
yea r o ld has been ex tensive ly show n to provide s ignificant
improvement in language perception and vocabul ary, often allowing
recipients to e nter first grade wi th lang uage ski ll s com parable to
children with norma l hea rin g.7.8 Rece nt evidence indi catin g that
impl antat ion as early as ix month o ld lead to better long-term
impro vements in language, socia l ski ll develo pment and s ignificant
adva ntages in parent-child bonding, has resulted in so me centres
implanting infa nts even earlier. 9 While the current guide lines advise
imp lantat io n at aro und two years o ld, studi es have shown little
additi ona l ri sk of implanting pati ents at a signifi cantl y younger age,
hence further shi ft ing the trend towa rd s ea rli er implantation.
Is thi s trend towards earl y imp lantati on signifi ca nt in te nns of
informed con ent? The ma in decisio n to implant has shifted away
fro m th e pati ent w hen ea rl y chi ldhood impl antatio n tarted becoming
co mm on. This has left parents w ith the full res pons ibility of choosing
implantati o n as we ll as the degree of deaf educa ti on the child will
receive if implanted . However, with children implanted earl ier,
parents are faced with shorter timelines during which to educate
themse lves abo ut the proced ure. Therefore, while implanting at six
months ve rsus two yea rs does not s ig nifi ca nt ly a lte r the child 's
abi li ty to co ntribute to th e decision, it may decrease the amount of
tim e th e parents have to co n ide r th e c ho ice and co uld arguably
pre ure pa rents into ras h decisions.

FUN DI NG OF COC HLEAR IMPLANTS lN AD ULTS AND
PEDIATRIC POPULATIONS
C urrent ly, three .centers (To ronto, London and Ottawa) provide the
over 190 coc hlear implant surgeries perfo rmed a nnua ll y in O ntario.
With wait tim es for imp la ntation surgery fa r above the recomme nded
three months for ped iatric popu lation and six mo nths for adu lts 10
th e Ontario government re leased an additiona l $5.9 mi ll ion i i~
fun?ing in .March ~0 11 to cut wait tim es in ha lf. 11 Un fortunate ly, it is
unlike ly thi s one-time fu nding package w ill address wai tl ist is ues in
the long-run, partic ul arly in the time-se nsitive imp lantation of
c hi ldre n as discussed above.
Specifica ll y in London, a s ingle annua l budget is provided for
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both pedi atri c and adult impl antations. There are several problems
th at arise from this fundin g mode l. Firstl y, as implant costs are
covered under prov inc ial hea lth fund ing, patients cannot pu rchase
their own implants in acco rd ance w ith the Canada Health Act.
Secondl y, since a lump sum is all ocated to the fundin g of impl ants
per hospita l, impl antati on can be undertaken onl y until the sum is
ex hausted in a g ive n fi sca l yea r. La tl y, due to the ev idence presented
above fo r ea rl y pedi atric implantati on, in fa nts must be im planted
w ith in a certai n w indow of time after the di agnos is. Therefore, as
more pediatric implants are perfo rm ed, ad ult patie nt are pushed
bac k on the wai t-li st fo r th eir implants. However, this fundin g mode l
does empower the hea lthcare prov ider in the audi ology tea m to
eva luate patients and ass ign the fundin g to those th ey determine
require it most.

UNILATERAL VS BILATERAL IMPLATATION
T he Canadian Association of Speech- Language Path ologi ts and
A ud iologist (CASLPA) pu bli shed th eir official posi tio n in th e
Journ al of Otolaryngo logy supporting bilateral cochl ear im plantati on
in all eli gib le children. Bilateral impl antations prov ide adva ntages in
so und loca liza ti on, speech isolat ion in no isy conditions and improved
deve lopment of the auditory system with few additi onal ri sks.
Additi ona ll y, by implanting both ears, the " better ear" (the ear th at
w ill fu ncti on better w ith th e impl ant) is always impl anted ,
maxi mi zing benefits fo r th e pati ent. 12 Hence, fo r the most part,
e ligible Canadi an child ren who rece ive impl antati o n undergo
simultaneo us bi lateral implantatio n as studies have shown no
advantage to implanti ng the second ear on a later date, particul arl y at
an older age. 13
While pedi atri c implantati on has been shown to be cost effecti ve
by several tudies 14, th e cost effecti ve ness of providing bilatera l
implantati on has been questi oned due to th e use of publi c fundin g of
th e impl ants. A systemic review done in th e U nited Kin gdom
comprised of 33 tri als, including two rand omi zed control tr ials
showed a fa r higher cost effective qua li ty-adj usted li fe -yea r returns
fo r unilateral im plantati on versus th e bilateral implantation in
pedi atri c and adult populati ons. 15 With mounting evidence and strong
recommendat ions in favo ur of bilate ra l implantati on, why is the cost
effecti veness of th e second im plant much lower than th at of th e first?
Firstl y, th e qu ali ty of li fe meas ures used to gauge improvements
fo llowing the second implant are much more un certa in and
inaccurate, as Bond 's 2009 rev iew ac knowledgesl 5 For example, it is
diffi cult to measure the improvement in quality of li fe ga ined fro m
increased abi li ty to loca lize so und or isolate speech. Secondl y, w ith
the ability of a unilateral impl ant to allow child ren to attend
mainstream school and often requ irin g almost no specifi c educati onal
assistance, the maj ori ty of savings are rea li zed w ith th e first implant
and are hence not refl ected in the additi on o f a second impl ant. Most
significantl y, the incremental improvement fro m hav ing nearl y no
hearin g to considerabl e hearing ac hi eved w ith a unilatera l impl ant is
bound to be considerably higher th an the improvement achieved w ith
the second implant.

Desp ite the effectiveness of imp lants, it is important not to di count
the services and supports the deaf commu nity provides to its
me mbers. Imp lantat ion i not a cure; rather, it i a upport ive
treatment tha t along wit h consi derable training allows for increased
fu nct ionin g. T herefo re, th ose im planted may sti ll find they can
bene fit fro m partici pat ion in th e deaf co mmuni ty through support and
sign language trai nin g.
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CONCLUSIONS
By many accounts, th ose who argue th at cochl ear impl antati on is
un ethi cal , ineffecti ve or simpl y not the best choice fo r profo undl y
deaf children appear to have been unsuccessful in preventing th eir
w idespread use. However, as impl antati on shifts fro m being a
novelty to the norm , th e issues of fundin g and cost efficiency appear
to have taken centre stage in Canada, and parti cul arl y in Ontari o.
With earl y bilateral implantation established as the best th erapy for
profo undl y deaf children, fu nding must be ava ilable to implant a ll
eligible children whose parents choose impl antati on. If such fundin g
is not available, as seen in some centres, wait lists w ill persist and
grow parti cularl y in adults as pedi atri c pati ents are g iven pri ori ty.
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Faculty Reviewer: Dr. DamirMatic, MD MSc FRCSC, Plastic Surgery

ur face allows us to convey o ur every tho ught and feeling
with those aro und us in a nea rl y instantaneous mann er.
Without our face, we wo uld be stuck in an e mot ion less a nd
depre si ng se lf-ex iste nce devo id of a prim a ry ve hi c le of
com municati o n. As soc ial beings, it is in our very nature to sha re our
ex pre ion with the o ut ide wo rld . It i likewise in ou r nature to
subconsciously j udge each face, ass ignin g certai n traits to parti cul ar
facial characteri tics. One of th e most impo rtan t characte ri sti cs th at
we judge is " beauty". Interestin gly, th ere is an unusually consistent
agreement of what is con idered " beautiful " a mongst different
cultures, but onl y when we are referring to the face rath er than the
body, a topic that wi ll be ex plored herein .

0

BEAUTY OF THE BODY
So what is it th at makes a perso n " bea utiful"? Bea uty is an arbitrary
and abst ract concept that is seemin gly difficu lt, if not impossi bl e to
define. Considerin g th e vast di ve rsity in thi s world and the countless
cultures it conta ins, one would expect that surely th ere must be
di ffe rent culturall y dependent standards of beauty. Howeve r, research
suggests that this is o nl y parti all y correct.
Research examining the ph ys ica l attracti veness of the fema le
body often uses the wa ist-to- hip rati o (WHR) as a qua ntifiabl e
meas ure. Indeed, studi es ha ve found th at males from most cultures
a nd across history stron gly prefe r female figures with a low WHR .,ln
the developed world, hea lthy females have hi gher leve ls of estroge n
that ca use more fat to be deposited o n the buttocks and hips rath e r
than on th e wa ist, leading to a low WHR.Thus, th e WHR is an
indicator of health status and ferti li ty, and male pre ference for lowWHR females is conside red an excell ent exampl e o f ma le assess me nt
of mate quality3

Matsigenka indi ge nous peo pl e in Peru, who are located in an
ex ten ive nature pa rk where access is restri cted solely to scientific
and offic ial visito rs and the vast majo ri ty of nati ves have never left
th e prem ises .3Their results showed that the WHR preferences of
ma les of thi s tribe di ffe red strikingly from those of the United States
control population as we ll a from othe r world c ulture , with the
" over-weight" female ranking hi g hest in the factors of attractiveness,
hea lthiness, and prefe rred pouse.3
The e were criti cal finding a they di ffe red striking ly from the
pre ferences of ma les in other cultures. The authors suggest that this
difference may be du e to the fact that in traditi o na l societies, physical
featu res may play a lesser role because mate c hoi ce is limited by
kinship rul es, an d potenti al mate have access to direct info rmation
about mate qu ali ty, suc h as age a nd history of illness.As a result, th ey
do not rely primarily o n information infe rred from physica l
appea rance . In contrast, in industrialized societi es, daily ex posure to
strangers from an early age may increa e the impo rtance of u ing
ph ys ica l featu res to assess potential mates based o n th ese factors .3
FACIAL BEAUTY
It seems reaso nab le to que ti o n > hethe r th e e relati ve cultural norms
likewi e influence our perceptio n of facial bea uty.Counterintuitivel y,
the answer is no. Be fo re ex ploring thi s to pi c, we must first consider
what exactl y facia l bea uty is and how to define it. The quest to find
to suitable defi nition of fac ial bea uty date back to antiquity, when
th e ancient Greeks be lieved th at beauty appeared when the ratio of
many di ffe re nt facial features to each other approached the va lue
I : 1.6 18, the o ca lled golden ratio. However, things are not so
simple, as furth er research has shown that facia l bea uty i more a
combinati o n of symmetry and a n idea l harn1ony of the facia l features
with each othe r. And mo t importa ntl y, as huma ns we have an innate
mec ha ni sm fo r detecting this elusive concept of beauty.

Despite th e ove rall prefere nce of men for wo men with a low
WHR, variations do ex ist, th ere by casting do ubt on the theo ry th at
thi s may be a uni versal idea l. Anoth er meas ure of body habitus is th e
body mass index (BM !), whi ch is a he uri sti c proxy for human body
fat. Different cultures a nd popul ati ons prefer females of differe nt
BMI and WHR du e to different sociocultura l influe nce . Undeniably,
th e effect of " Westerni za ti on" may be contributing to a more
universal stand ard o f bea uty, but thi is not due to our innate
evolutio nary preferences. Rega rdl ess of th ese influences, a study
comparin g fema le phy ica l attracti ve ne
between Japanese and
British parti cipants found that Japanese men preferred images of
wo ma n with signifi cantl y lower BM! s th an Britons and likewi e
we re mo re re li a nt o n bod y s hape when judging ph y ica l
attractiveness.

.T he re are several exa mple that seem to re inforce this concept.
For Insta nce, superm odels, arguab ly con idered the mo t attractive
membe rs of We tern ociety, have the least degree of facial
asymmetry when compared to the ge ne ral population . Facial
a ymmetry ex ists a long a gradi e nt in our population and it is clear
th at we have evo lved to tol erate some deg ree of thi asym metry.

However, th e fl aw with th ese studi es in general is th at every
culture tested so far has been ex posed to th e potentially confoundin g
influence of Western media . A la ndmark study by Yu and Shepard
assessed the WHR preferences of a c ulturall y iso lated populatio n of

Interesting ! ~, studi es ha~e shown that averag ing a random group
of. faces res ults 111 a synthet1 c face more attrac ti ve than a ny of the
o n g mal faces .,The faces used in these a na lyses consisted of thirtytwo completely random faces from a pool of diffe rent c ul ture , yet
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Symmetry is an impo rtant a pect of facia l bea uty and i tied to
evo luti onary fitn ess, where le ft-ri ght bilateral symmetry describes
hea lth a nd hi gh geneti c quality, and devi ations from it may indicate
poor qu alities and there fore form a basis for rej ection of a potential
mate.,
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observers always ranked the composite face as be ing the most
attractive. Paradox ica ll y, th i suggest that the idea l ham1ony of the
fac ial featu res that we consider to be " beautiful " is actua ll y as close
to "average" as pos ible. Naturall y, such statements have draw n
criticism from many indi vidua ls who refu se to be li eve that beauty
may in any way related to "ave rage ness".
It is critical to note that the com putatio na l "average" of fac ial
features that is considered attractive in thi s case is completely disti nct
fro m w hat cul ture commonl y refers to as an "average" fa ce, whi ch
natura ll y has a nega ti ve connotati on and is not co nside red
" beautiful ". There are certa inly unique and interestin g fea tures that
may add to the perce ived attractiveness of an indi vidua l's face, but it
is important to realize that they must be associated with an "average"
face and must be harmonio us with the other faci al fea tures.
Th ere have bee n a rg u me nts th at bea uty is a c ul tura l
phenomenon engrained in us repeatedl y th ro ughout our yo uth,
resul ting in a bia ed preference such as that of male for fe males with
a low WHR ratio . However, there are many exam ples that d isprove
this theory. Eleven separate meta-ana lyse have revea led very hi gh
agreement in fac ial-attracti veness ratings by raters both within their
own cul tu re, and across other culture ., In fact, the effect sizes we re
more than double the size necessary to be considered large and
thereby strongly suggest a uni ve rsal sta ndard by whi ch fac ial
attractiveness is j udged.
ln order to negate the possible influence of Western media, a stud y
examin ing preferences fo r fac ia l symm etry betwee n Briti sh
individuals and the Hazda, a hunter-gatherer soc iety of Tanzania,
li kew ise fo und that facia l symmetry was more attracti ve than
asymmetry across both cultures. These findin gs fu rther question the
ass umpti on that ratin gs of facial attracti veness and ideals o f fac ial
" beauty" are culturall y unique and are consistent with the fac t that
young infa nts prefer to look at face that adults likew i e consider to
be attractive.
It is im portant to realize that there are exogenous fac tors that
augment attracti veness and beauty as it pertains to mate selection,
whi ch is prec isely why it i such an elusive concept to defin e. Dutton
argues that based on Darw ini an aestheti cs, indi vidua ls consciously
select mates who have certa in characteristics, and that such
characteri stics in fac t may make the person more attracti ve and
" beautiful " to them. Dutton furth er states that it is human personali ty
that adds another dimension of beauty, with traits such as a delightful
sense of humor and generosity being attractive. ! ? Although it is still
evoluti onaril y based on fi nding a healthy mate who is able to provide
care, it is thi s rationa l intention combined with physica l appearance
that forms a complete v iew of beauty and attracti veness.

CONCLUSION
Beauty is an elusive concept that is envied and sought by many, yet is
extremely difficult to defin e.Aithough the beauty of the body has an
evolutionary basis, the concept of the ideal body is a cultural
construct that has been influenced and continues to be influenced by
culture and media. Conversely, fac ial beauty is a biologicall y
ingrained concept based on symmetry and an idea l coalescence of
that fac ial features with each other that transcend barri ers of culture,
media, and time. Ultimately, concepts of beauty and attracti veness
are evoluti onaril y based, but cannot be looked at narrowl y as based
so lely on appearance as they are augmented by exogenous fac tors.
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Incidence of acute respiratory distress
syndrome and acute lung injury in patients
requiring prolonged mechanical ventilation
Paul Kudlow, B.Sc. (Meds 2013), Chu L, B.Sc, Herridge MS, M .D., M.P.H
Faculty Reviewer: Nigel Paterson, M .D.

rim aril y affect ing criti cal care pati ents, Acute Lung Injury
(ALI) and its more severe variant, Acute Respiratory Di stress
Synd ro me (A RDS ) a re devastatin g clini ca l syndromes,
h av in g l o n g- t e rm functional a nd neurop syc hol og ica l
conseq uences I ,2,3. Further characterized by ac ute hypoxemia,
bilateral pulmonary infiltrates on frontal chest radiogra ph y, and no
clinical evidence of left atria l hypertension, AR.DS/ ALl are severe
inflammatory conditio ns of the lung parenchyma4 ,5. The resulting
severe hypoxemia combined with the ex ten sive release of systemic
inflammatory medi ators often leads to multiple o rga n failure;
responsible for hi gh rates of morbidity and mortality in the
populati on6. Despite many recent advances in our understandin g of
the pathoph ysio logy, trea tm ent, and long-term outcomes of ARDS/
ALI , in cide nce and preva le nce of these conditions remain s
un certai n6. The un certainty in tum refle cts the heterogeneity of th e
syndromes, the lack of de finitions for th e underl ying disease
processes, and fa ilure to uniforml y defin e the population within
which pati ents wi th AR DS/ALI are identified5 . The inci dence of
ARDS/A LI in th e United States has been estimated to be around
300,000 ca es per yea r, but thi s may be an underestimate6. A recent
study, conducted by Rubenfeld et al. examined th e gene ral ICU
population and found the incidence of ARDS/ ALI to be somewhat
hi ghe r, at app roxi mately 58.7 and 78 .9 per 100,000 respectively;
giving an a nnual estimated incidence at around 141 ,500 and 190,600
cases of ARDS/A LI respecti ve ly in th e United States per year6.

P

RESULTS
The study sample contai ned 82 pat ients . They had a median age 59
yea r , the male : female rati o was 1.4:1, and 45% of those sampled
were found to have ~ 2 comorbidities. The median APACHE II core
of wa 25 a nd a the median ICU LOS of was 37 days. In our study
sample, 72% survived until ICU di charge.
To date, the records of 25/82 pati ents have been examined (by both
co-a utho rs) for the presence of ARDS/ALI. Of this sample, 2 1/25
(84% ) had radi ogra phic ev idence of bilateral infiltrates and fulfilled
AECC criteri a for AR.DS/ALI. Interobserver variability, measured by
kappa score, was 0.60 (Fig ure I).

DISCUSSION
In thi s limited ample, there were a hi gh pro portion of patients who
fulfilled the criteri a for ARDS/ALI. Although the re was insufficient
data to acc urat ly calcul ate incide nce at present, our preliminary
propo rti on of 84% , ugge t that the incidence of ARDS/ALI in tho e
mec ha ni ca ll y ventilated for at least I week, likely exceeds 58.7 and
78 .9 per I 00,000 pe r o n- years respecti ve ly as previou ly de cribed
by Rubenfe ld et al. in their ampl e of general ICU patients6. Our
result were trengthened by relatively good agreement between
independent e aluators; we measured a kappa score of 0.60 (Figure
I ).

The purpo e of the current study was to dete rmin e th e incide nce
of A RDS/A LI in a pilot sam pl e from a prospecti ve multi -centre
follow-up of criti ca ll y ill pati e nts mechani ca ll y ve ntil ated for at lea t
one week - the Towards RECOVE R stud y? . The incidence of A RDS/
A Ll in pati e nts requiring pro lo nged mec hani ca l ve ntilati o n is not
kn own. We hypoth es ized th at th e incidence of AR.DS/ALI would
exceed that found in ge neral ICU pati ents, as cited above.

METHODS

•

.

i

N

....

0

•

• •

• •

...,
"'c

As part of the Towards RECOVER study protocol?, pati ents were
included if they were ~ 16 year o f age and mec hani ca lly ventil ated
for at least one week . (n= 82) . Chest imag ing was performed dai ly
for th e first ICU week and each Monday a nd Thursday th e rea fter.
in vesti gators (PK, LC) unde rwent systemati c training on Chest XRay (CXR) inte rpretation for ARDS/ ALl by a standardi zed on line
educational tutoria lS. CX Rs were divid ed into 4 qu adrants, each
ana lyzed fo r th e pre ence or absence of bi late ral infiltrates consistent
with non-cardi ogenic pulmonary edema. Diagnosis of ARDS/ALl
was based on American Europea n Consensus Conference on AR.DS
(AECC) guid elines. Data was ana lyzed to de tennine the percentage
o f radiograph read inde pendently as ARDS/ ALI by each reader and
interobserve r variability was be calcu lated (kappa-stat istic)9. All
analyses were perform ed using appropriate so ftware.
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Fig ure I. The area of the circ les is proportiona l to the number of
subject give n a particu lar pair of ratings.
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Taken together, our preliminary result sugge t that ARDS/ALI are
likely under recognized conditi ons, particul arl y in cri tically ill
patients requiring pro longed mechani ca l ventilation. Earlier tudies
have estimated the mortality due to A RD I A Ll at aro und 133,500
deaths per yea r in the Uni ted State 6. Give n the possible under
recognition however, ARDS/ ALI are conditi ons likely responsibl e
fo r even more deaths in the population. Besides mortali ty, ARDS/
ALI also leads to large amoun ts of costl y and often debi litating
morb idity in urv iving pati ents and their caregiver I ,3,6. Outcome
studi es have co ns i te ntl y fo und s ig ni fica nt fun c ti o na l a nd
neuropsyc hological derangement at both I year and 5 yea rs po t
illness \ ,2,3. Perhaps better identification of A R.DS/ALJ in the fi r t
place may help to more efficientl y allocate hea lth care resources - in
tum potentia lly preventing orne of the typica l long-term sequelae
currently experi enced by surv ivo rs and their caregivers.
Before making any fi rm conclusions however, it should be noted
that although the results of our preliminaty study are suggesti ve of
under recogni tion of AR.DS/A LI, they are subject to a number of
important limitations. Particularl y, thi s stud y wa not onl y limited by
ample ize, but also, data coll ected was subj ect to survi vorship,
selection, and ascertainment biases. Additi onall y, analysi of data
collected was limi ted by the level of training of the independent
evaluator (PK, LC). The independent evaluators were trained using
an online sta ndardized tu torial to a sist in the detennination of
bilateral pulmonary infi ltrates as per AECC guideline 5,8. Although
good agreement was measured benveen independent evaluators, the
data remain to be fo rmall y evaluated by a trained phy ician.
Therefore, larger fu ture studies are needed to va lidate and confi m1
the preliminary re ult of thi current tudy.
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Shortness of breath in a 12 year-old boy: a
classic presentation of stage IV Hodgkin's
Disease?
Michael Livingston (Meds 2011)
Faculty Reviewer: Dr. Neil Merritt, M.D., FRCSC

hane is a 12 yea r-o ld boy who prese nts to yo ur offi ce w ith
wo rsenin g shortness of breath o n exe rti on. Hi s fa the r ex plains
that hi s son had severe asthm a when he was yo un ge r. He wa
adm itted to hospital when he was 2 yea rs old and put on a vent ilator
in th e intensive care un it when he was 4. Hi s symptoms have been
much better since then. In fac t, Shane has n't had to use puffers very
much at all up until a few month ago. He started u ing Ye ntoli n
aga in while playi ng soccer and does get some relief with thi s.

S

IS IT ASTHMA ?
Yo u take a thoro ugh history from Shane 's fath er. He notes that th e
shortness of breath has come on gradu all y over th e last few month s
to the point where it ca uses Sha ne diffi c ulties several times per week.
There is no hi story of producti ve co ugh, and no fever, ni ght sweats or
we ight loss. Shane has no oth er medi cal conditi ons, no know n
allergies, no previous surgeri es, a nd his vaccinati ons are up to date.
Hi parent are from Barbados but he ha never been out of th e
co untry himself. Shane 's 13 year-old brother had a co ug h recentl y
but there are no oth er sick contacts.
O n examinat ion, Shane is a lea n-l ookin g child but otherwise
appea rs we ll. Head circumference a nd height are above th e 50th
percentile and we ight is above th e 25th percentile. He has no
cerv ica l, suprac lav ic ul a r, infrac lav ic ul a r, ax ill a ry, o r ing uin a l
lymphadenopathy. His respirato ry exam is significant fo r mild
wheeze thro ugho ut but no crackl es or areas of decreased breath
so unds.
You ex pl ain th at Sbane's symptoms most like ly repre ent
worsening asthm a. You give Sha ne a presc ripti o n fo r inhaled steroid
and e nco urage him to use it tw ice per day. Yo u also give him a re fill
for Vento!in and ex pl ain that he can use it wheneve r he fee ls sho rt o f
breath . Shane's fath er agrees to foll ow- up with yo u in one month .
IS IT INFECTIO US?
Yo u see Shane and hi s fath er bac k in clinic one mo nth later. Hi s
fath er looks very concern ed. The hortn ess o f breath co ntinues to be
an issue and now Shane has a rash. The ras h sta rted be hind hi s kn ees
and has spread to hi s trunk, a rms, and neck. The ras h is pruritic and
both ers Shane quite regul arl y.
Yo u do a full review o f systems a nd di scover tha n Shane has
been feeling generall y un we ll recentl y. He repo rts no ni g ht weats,
feve r, or we ight loss, and no pain at ni ght. Exa minati on o f th e ras h
revea ls numero us crusted papu les meas uring 3-5 mm in di ameter
(see Figure I). Hi s fath er assures yo u th at Shane has already had
chi cke n pox. The ph ys ical examinati on is oth erwi se th e same as
Shane 's prev ious visit. There is no lymphade nopath y and th e mild
wheeze heard o n res piratory exam is un changed. You presc ribe
hydrocorti sone c ream fo r th e ras h and set up an outpati ent re ferral to
In fec ti o us Di sease.

18

Figure 1. Crusted papules measurin g 3-5 mm consistent w ith
pityriasis lichonoides [4).
WHAT ELSE CO LD IT BE?
hane is seen by yo ur co lleague in Infecti ous Di ease six weeks late r.
hane has now deve loped a dry coug h. The ras h is till prese nt
alth o ugh th e itc hine s i re lieved so mew hat by th e topi cal
hydrocorti so ne. A rev iew o f syste ms reveal s th at Sha ne has now lost
abo ut 5 pound since the wo rsenin g of sho rtn ess of breath began .
hane deni es feve rs and ni g ht sweats, but hi s fath e r ays that, " he's
bee n feeling rea ll y un we ll recentl y." Phys ical exa minati on reveals
anteri or cervica l a nd suprac lav icul ar lymphade noa pthy. The nodes
a re nontender, rubbery and range in size from 1 to 2. 5 e m .
Respiratory exam is significant for w heeze but th ere are no crackl es
or areas o f decreased breath so unds.
Yo ur colleag ue ex pl ains th at he needs to get a c hest x-ray as part
of hi s workup . He agrees th at Shane is quite sick a nd will need more
te ts. He sends Shane to the Pediatri c Emergency Department for
furth er eva luation .
HOW BAD IS IT?
Sha ne is as essed in th e Emergency Departm ent later that afternoon .
He has a fever of 38 .5 degrees Celsiu s, tachycardi a with a heart rate
o f I ~5 ~ and oxygen saturati o n of 94% on room air. The Emergency
Ph ys1c1an o rders a chest x-ray (see Fig ure 2) a nd bloodwork. The
chest x-ray reveals mass- like pulmonary opac ities in both lungs and
enlargement o f th e hila and supe rior medi astinum .
B loodwork is signifi cant fo r a white b lood cell count of 32.0

~hich con ist o f 24.0 ne utrophil s a nd 4 . 1 eosino phil s. H emoglobi~
IS decreased slightl y at 129. Platelets are ele vated at 55 1 C reacti ve
protein is 111 .8, and erythrocyte sedimentation rate i '54. Lactate
dehydrogenase is hi g h at 61 6 but urate and cal c ium a re normal.
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Figure 3. Compu ted tomography sca n of the thorax showi ng masses
in the lungs and hil ar and medi stinallymphadenopathy.
Figure 2. Chest x- ray of a 12 yea r-o ld boy, how ing a medi a tina]
mass, hil ar enlargement, and patchy mass- like opacities in the lungs.
Shane is admitted to hospital by the inpatient Ped iatrics team for
further workup. The differentia l includes infection, va culiti , and
ma li gnancy. He is placed on airborn e contact precauti ons and
admitted to a negati ve pres ure room until tubercu losis can be rul ed
out.

IS IT CANCER?
Shane undergoe a CT scan of the pelvis, abdomen and th orax the
following day (see Figure 3). The CT revea ls multiple solid nodules
in both lungs, as well as mediastinal and hil ar lymphadenopath y.
Enlarged nodes are seen in the para-ao rti c area but there are no signs
of a primary tumor.
General urgery in consulted to obta in a biopsy. Shane and hi s
parents remai n anxious over the next few days as they wa it for a spot
to open up in the operating room. In the meantime, Shane's white
blood cell count remains in the hi gh 20s and pl ate lets rise up to 762 .
Shane goes to the operatin g room three days afte r hi s admission for
bi opsy of a superficial supraclav icular lymph node and skin under
genera l anesthetic. Frozen section of the lymph node is pos iti ve for
malignancy but fl ow cytometry is normal. A definite diagnosis is
deferred until permanent sections can be processed.
Over the next few days, Shane's shortness o f breath worsens.
The vasc ulitic bloodwork comes back norma l and acid-fast cultures
are negati ve for tuberc ulos is. The fin a l patho logy report i relea ed
one week later indicatin g Hodgkin 's Di sease, Nodular Scleros ing
subtype.

IS TIDS STORY TYPICAL FOR HODGKJN ' S DISEASE?
Shane's story ma y seem somewhat convo luted but hi s symptoms are
actually quite typical. In children, less than 20% of patients present
with one of the classic " B" symptoms of Hodgkin 's Disease (weight
loss, fe vers, and drenching night sweats) [ 1] . In fact, the most
common presentation in children consists of painless cervical
lymphadenopathy (which occurs in 70-80% of cases) and/or a
mediastinal mass (in 50% of cases) [2] . Shane's initial chief
complaint was shortness of breath due to the mass e ffect of
mediastinal lymphadenopathy. This eventual ly progressed to a cough
and hypoxia. The lesions in the lungs represent a combination o f

contiguous spread from hilar lym phadeno pathy and metastases to
lung parenchyma [3].
The ras h and itchiness that Shane ex perienced isn' t that unusual
either. In fact, some patients will give a hi story of insid ious itchiness
for months before being diagnosed wi th Hodgkin 's Di sease [2] . The
sk in les io ns in thi s case most li ke ly represented pityriasis
lichenoide , which is a sociated with lymphoma [4].
Shane 's initial bl ood wo rk is classic fo r Hodgki n's Di sease. At
first glance, the elevated white bl ood ce ll count consisting almost
entirely of neutrophil s would seem to suggest an infectious etio logy.
This is certa inly supported by the hi gh pl atelet count, C reacti ve
prote in, and erythrocyte sedimentati on rate. (Indeed, in this case,
Shane remai ned on airborn e contact precauti ons until tubercul osis
was fonnall y rul ed out with a negative acid- fast bacilli culture.)
Neverthe less, a compl ete blood count characteri zed by neutrophilia,
eo inophili a and thrombocytos is is cia sic for Hodgkin 's Di sease in
children, and is not du e to underl ying in fec ti on [I , 2, 5].
The presence of elevated lactate dehydrogenase would lead to
some suspect tumor lysis syndrome. The elevated levels seen in thi s
case ac tuall y represent a hemo lytic anemia, which is not un common
in Hodgkin 's Di sease [6]. The norm al serum electrol ytes and urate
leve ls seen here stand aga inst the presence of ongoing tumor lysis.

WHAT lS THE PROG NOS IS?
Shane has stage NB Hodkin 's Di sease acco rding to the Ann Arbor
Staging C lass ificati on [5]. He has diffuse invo lvement of I or more
extral ymphati c organs (stage IV) and has 8 symptoms (B). Thi s
places Shane in the hi gh-ri sk category [5, 7]. Even so, with proper
treatment and monitoring the 5-year survi va l for children like Shane
is up to 90% [7 , 8]. Shane was started on induction therapy whil e in
hospita l, consisting of cyc lophosphamide, v incri stine (Oncovin),
procarbazine, and prednisone (COPP). He was di scharged home once
hi s breathing improved and will complete three more courses of
treatment be fore rece iving radiati on therapy.
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Obstructive sleep apnea in children: the when,
how and why of screening
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bstructive sleep ap nea syndrome (OSAS) is part of the
spectrum of sleep disordered breathing (S OB) and is
estimated to occur in about 2% of the pediatric population , 1
whereas 2-5% of adults are affected 2 The peak incidence of OSAS is
in pre-schoo lers, when ton illar hypertrophy i most common .3 Like
adu lt OSAS, pediatric OSAS is caused by periods of complete or
partial upper airway collap e during leep, disrupting nonnal sleep
patterns and resu lting in intennittent hypoxia durin g apne ic and
hypopneic episodes. It i believed that OSAS res ults from a
combination of anatomic abnormalities resulting in decreased space
and increased pressure in the upper airway, and neuromuscular or
funct ional abnorma lities that cause decreased muscle tone wh il e
sleeping and lead to periodic a irway co ll apse.3•4

0

There is an increas ing awarene s about th e preva lence a nd
consequences of OSAS in the adult popul ation among primary care
physic ian s, a ll ow ing for improved screeni ng, diagnosis and
treatment. 5 However, the recognition of thi s disorder in the ped iatric
population is much more diffi cult, and current screening among
primary care ph ysicians is inadequate 6 Children with OSAS present
with different symptoms, have different ri sk factors , different
pathophysio logy, and require different manage ment strategies than in
adults.4 •5.7

CLINICAL IMPORTANCE
OSAS in chi ldren has been shown to contribute significantl y to
childh ood morbidity with consequences seen in multiple systems.The
severity of sleep apnea has a dose-dependent re lationship with
decreased left ventricular function leadin g to congestive heart failu re
and cor pulmonale. 1 Plasma C-reactive protein level , a marker of
inflammation with an important ro le in atherogenesis, have a lso been
shown to be elevated in children with SDB,8 and fasting in ulin
levels a lso seem to correlate with the disease severi ty, independent of
BMJ.9 Failure to thrive and a low weight index have been noted in
children with OSAS , possibly du e to changes in hormonal release
during apneic episodes. 1o

It is known that OSAS in adu lts resu lts m daytime
hypersornnolence and psychological seque lae such as di sturbed

concentrat ion and memory,2 however in ch ildren the deficits in
neuropsychologica l and behavioural functioning caused by untreated
OSAS can severely affect deve lopment, interfere with learning, and
cause symptoms that may be diagnosed as attention-deficit
hyperacti vity disorder (ADHD). In one well- known tudy, it was
found that 33 % of chi ldren with ADHD exhibited symptoms of SOB
w hile only about I 0% of children without AD HD in the study
ex hibited such symptoms, with the auth ors postulat ing a causa l
relati onship . 11 This hypothe is has been strengthened by the finding
that symptoms of inattention and hyperactivity predictably improve
after surgica l treatment for OSAS . 12

DI AGNOSIS
RJ SK FACTORS
Obesity is a common ri sk factor in both adu lts and chil dren, as
increased fatty tissue in th e neck resu lts in increased upper airway
resi tance. 13 However in childrenOSAS is sti ll most common ly
related to ade notonsillar hypertroph y.3.7 Obstructive leep apnea is
also assoc iated with oth er medi ca l disorders such as Down
syndrome, anatomic crani ofac ial abnorn1a li ties such as micrognathi a,
neuromuscular disease including cerebral palsy, and conditi ons such
as sickle cell disease and laryngo malac ia. 1 Children with any of th ese
conditi ons should be seen as high-ri sk and carefu ll y screened .

HISTORY
A thorough sleep hi story should be taken from the parents, aski ng
spec ifica ll y about I) snoring, 2) apneic episodes,3) laboured mouth
breathing, and 4) restles ness.3 Habitual (ni ghtl y) snoring is the most
sen iti ve indicator, as OSAS is rarely seen in its absence. I However,
snorin g occurs in up to 12% of chi ldren and therefore ha poor
spec ificity. I Differentiati ng between primary noring and OSAS can
be difficult based on hi story alone. Note that th e loudness of snorin g
does not necessaril y corre late to the degree of obstru ction !1
Dayt ime symptoms may include excessive daytime sleepi ness,
or more commonl y, hyperactivity with attention and concentrat ion
prob lem , possibly resulting in behavioura l difficulties and learning
prob lems. The Canadian Paedi atric Society and Coll ege of Fami ly

Table 1. Differences in th e C linical Presentation ofOSAS between Children and Adults
Most Common Ri sk Factor
Daytime Symptoms
Epidem io logical Di stribution
Polysomn ograph Findings
Most Common Treatment

C hildren
rronsillar hypertrophy
Obesity is secondary)
Hyperacti vity!Jnattention
1:1 Males to Females
!Awakening durin g REM sleep
Fewer arousa ls
Surgery (adenotonsi lectomy)
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Adults
Obe ity
!Daytime sleepiness
~ : 1 Ma les to Females
!Awakenin g during slow-wave sleep
More arousals
CPAP
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Phys icians of Ca nada endorse the Greig H ealth Record which
recommends ask ing about s leep habits, daytime somno lence as well
as co ncentration and irritabili ty at a ll periodic hea lth visi ts for
children ages 6-17. 14
The ' BEA RS' scree nin g qu esti o ns, a use r-fri endl y too l th at
encourages obta ining sleep informati on fro m pediatric patie nts, has
been shown to increase the like lihood of identifying s leep problems
in a primary ca re setting, 15 a lthough it has not been va lidated to
spec ifi call y identi fy OSAS.

PHYSICAL EXAM
Adenotonsillar hypertrophy may be u pected o n phy ica l exam by
the observation of mouth breathing, hyponasa l speech, or direct
vis ualizati on on exa minati on of the o ropharyngea l cav ity, I a lthough
vis ual inspecti on may give a fa lse impress ion of to nsill ar s ize and is
therefore not a re liable method of diagnosis. 1 Refe rra l to an
otolaryngologist wi ll a ll ow c loser visua lization of the tonsil s,
adenoi ds, tongue base, and soft palate through fl exible laryngoscopy,
and may detect subtl e structural abnorm a lities in the a irway.
Recognition of risk fa ctors for OSAS such as cra ni ofacia l
abnormalitieso r obesity on physical exam may also increase the
c linician's suspicion of the diagnosis.

FURTHER TESTING
Audi otapes or videotapes taken by the parent of th e sleep ing child
may sometime be used by healthcare tea m to li ten and watch for
observable apneic episodes. tudies exa minin g the reliability of this
method of testing have found mixed results w ith genera ll y poo r
predi cti ve va lues 3 While this is a non-invas ive and ava ilable means
of creening and may be of orne use to c lini c ians, if the results are
negative and you are still suspi c ious of OSAS in a pati ent, they
sho uld be referred for a sleep tudy.
The go ld standard for di agnos is of OSAS is a sleep stud y, or
polysomn ograph y. It will re liabl y differentiate betwee n primary
snoring and 0 AS, a nd ca n dete rmin e the seve rity of th e syndrome.
Results mu t be interpreted based on age-adjusted criteri a, as OSAS
affects sleep pattern s in children di ffe rentl y th an in adults. 1 C hildren
wi th OSAS ex peri ence grea ter obstru cti on during REM sleep, 16and
have fewer aro usals associated with apneic epi sodes. 7 C hildren also
ex peri ence greate r desaturati o n durin g apne ic epi odes. 3 Theduration
of obstructi on req uired for a definition of apneaand the thresho ld
number of apne ic episode for a diag no i of a di order must be
adjusted due to th e increased respiratory rate see n at base line in
children, and it is common to see hypoxia due to prolonged parti al
obstruction rather than the cyc lical complete obstruction see n in
adults. I Thi s is known as obstructive hypoventil atio n.
World w ide, the demand fo r po lyso mnograph y i hi gh but
provi sion is limited and is costl y. The refo re it is often diffi cult to
obtain thi s test in a tim e ly fashion 3 In th e absence of a n eas il y
accessible s leep lab, ni ght oximetry testing may be co n ide red,
meas uring epi sodes of desaturati o n througho ut the ni g ht with an 0 2
saturation probe on the c hild 's finger. Thi s te t ge nera ll y ha a good
pos iti ve predicti ve va lue, but if it is negati ve th e pati e nt should sti ll
undergo poly omnography to rul e out OSAS. 17

MANAGEMENT
Adenotonsillecto my is usuall y the most appropriate the rapy fo r
children with OSAS. In children with documented adenotonsillar
hypertrophy, 75 to I 00% wi ll have symptom resoluti on as we ll as
normal po lyso mnograph res ults afte r surgery. 1 Patients with obes ity
or unco rrected crani ofacia l abnormalities may see poorer results on
post-o perati ve po lysomn ograph y. 1
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"BEARS" Screening Questions:
B=Bedtime Issues
E=Excessive Daytime Sleepiness
A= Night Awakenings
R=Regularity and Duration of Sleep
S=Snoring
Studies have repeatedl y shown dramatic improvements in
quality of life sco res, behavioura l symptom s, depression ,
hyperacti vity and somatizati o n for c hildren with OSAS after
adentons ill ectomy. 18 Interesting ly, c hildren w ith milder form s of
sleep di so rdered breathing also show imilar improvements after the
surgery.
As with a ll therapies, the ri sk of the procedure must be
considered. The mo t serious ri sks of ade noto nsillectomy include
respiratory complicati ons, and it is thought th at patie nts with more
evere OSAS o n polysomnography pre-op a re more likely to
ex peri ence respiratory com promi se post-op. 12· 18-20 Therefore these
patient hou ld be ho pitalized overnight and mo nito red carefull y
post-operatively.
For patients with incomp lete resolution of symptoms after
surgery, or for those patients w ho are not surg ical candidates,
continuou posi tive airway pressure (C PAP) therapy has been shown
to be effecti ve. 1 However, it i often not to lerated in the yo un ger
population and must be frequent ly adju ted to fit the growing child,
resultin g in poor compliance.
lt is also importa nt to assess for and treat behav ioural sleep
di stu rbance in children diagnosed wi th OSAS, e pecially those that
continue to have daytime symptoms. Behavioural sleep di sturbances
including bedtime resi tance, problematic leep a ociation , a nd
prolo nged nocturn a l awakeni ngs, have a hi gh co-morbidity with
OSAS in children, and inde pende ntl y put th e c hild at an increased
risk for neurocogniti ve and behavioural issues. 21 Therefore it is
important to implement behavioural interventions w hile concurrently
in vest igating and treati ng for OSA

SUMMARY
Primary ca re phy icians have an impo rtant rol e to play in the
identificat ion and di agnosis of OSAS in c hildre n. However sleep
di sorder are underdi agnosed in primary care practices, primarily
beca use ph ys icians do not ask pa re nts about the symptoms of
di so rde red lee p. In genera l, it i difficu lt to accurately diagnose
OSAS on hi story and physica l examin ation alone. Howeve r, primary
ca re ph y icia ns s hould be perfo rmin g reg ular creening for
symptoms of OSAS as recomme nded by Ame rican Acade my of
Pedi atri cs.
norin g is the most sens itive indicator. If clinical
suspic ion is hi gh based on risk factors and/or hi story and phy ical
exa minati on, th e chi ld ho uld be referred to an otolaryngo log ist or
direct! ~ to po lyso mnography for furth e r testing. Complex patient ,
mcludmg mfants and those with co ngenital abnormalities, should be
refened to an otolaryngologi t. It is important to ide ntify and treat
pediatn c O~AS early in order to prevent serious morbidity, including
neurobehav10ural seque lae such as symptoms of inattentiveness and
hyperactivity.
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An interdisciplinary approach to voice
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he larynx serves th e du al purpose of airway protection and
phonati on. It is covered by the epig lottis during swallowing,
and i patent during re pirat ion and phonati on, during w hi ch
a ir passes past the modified sides of the larynx, the voca l fold s or
cords. The upper border of the conus e lasti cus is thi ckened , which
forms the true voca l fold s. Histolog ically, the outermost layer of the
voca l fold is campo ed of tratified squamou epithe lium . Deep to
this li es the lamina propri a, a fl exible fibrou s layer contai ning e lastin,
collagen, an d fibroblasts. The la mina propria is divided into three
c linicall y impo rtant layers - superficial , intermediate and deep,
which become gradually mo re stiff a th e co ll agen to e lastin rati o
increases. Deep to this membranous cove r lies the body of the
thyroaryten o id muscle.

T

Phonation requires the prese nce of not on ly the vibratory voca l
fold s, but other upper airway structures - the pharynx, ora l and nasal
cavities - for resonance and articu lation . Phonation is produced
during the g lotti s cycle. The fir st step is the accum ul ation of air
press ure beneath the approximated voca l fo lds. At a particular
press ure, call ed th e phonati o n threshold pre sure, th e voca l fold s
begin to part in a wave- li ke fashion from inferior to superior. The
voca l fold s are s imultaneo us ly moved laterally by the a ir column ,
and quickly return to the midline du e to the ir intrinsic e lasti c
properties. Thi cycle repeats approximate ly I 00 tim es per seco nd in
men and 220 times/second in women 1. The a mplitude, frequency,
wave morpho logy and periodicity (vo lume, pitch and voca l quality,
respecti ve ly) are va ri ed by c hanges in a ir press ure and/or ti ss ue
quality. Amp litude is increased or decreased by providing a greater or
lesser ex haled force , paired with an in crease or dec rease in tens ion of
voca l fo lds (affected princ ipa ll y by the th yroa ry tenoid mu c le) . Pitc h
is increased by co ntractio n of the cricoth yro id musc le, whi c h
lengthe ns and thin the voca l fold , an d dec rea ed by co ntract ion f
th e thyroaryte no id muscle, whi ch sho rten th e fold a nd increases
th e ir mass .
Di so rde rs o f and di sruption s to th e voca l fold s may have
d evas tat in g co nsequ e nce in eve ryd ay co mmuni ca ti o n, a nd
es peciall y for th ose who re ly o n thei r vo ices profe s io na ll y. T hi
arti c le wi ll address so me of th e most common voca l di sorders of
profess iona l s in ge rs, th e ir ca use, ide nti fi ca tion , mana ge ment,
prevention , and th e ro le of a multidi sc iplinary tea m in mainta ining
voca l hea lth .
VOCAL HYGIENE AN D T H ERAPY
First- li ne trea tm e nt for many orga ni c voca l diso rders, such as
nodu les, po lyps and cysts is voca l therapy. Vocal th erapy serves to
impro ve voca li za ti on techn iqu e , a nd to minimi ze harmful
beha v iours, whil e max imi z ing hea lthful o ne . Ho lmberg et al. used
voice the ra py in the treatment o f voca l fo ld nod ul es, and showed
perceptual improvement in voca l qua li ty, a nd reduction in nodul e

24

size2 The ir protocol for vocal therapy co ns ists of 5 d ifferent
approaches to voca l health, and it was concluded that the therapy as a
who le is required to significantly improve voca l qua li ty 2 . The first is
voca l hyg iene, whi ch enta ils patient ed ucation on normal phonation,
types of abu ive behav iours (vo ice overuse) and a busive substances
(smoke and caffeine), and etiology and conseq uence of voca l
nodul es. The second i re piration - a focu s on reducing the effort of
speech breathin g and exercises to tra in the proper management of air
suppl y. Third are direct faci litation mea ures which aim to reduce
loudness, coup led wit h "yawn-sigh" exercises, w hi ch rel axes voca l
muscul atu re and so ft en voca l onset. The fourth is relaxation
techniques and stress management. Last, the patients were instructed
to carry ove r all of th e above tec hniques to real ituations 2 . One
rando mi zed control trial demonstrated the efficacy of voca l th erapy
in pati ents who acquired voca l impairment after treatment (either
laser o r radi o thera py) for early g lo ttic cancer. Significant
impro eme nt were no ted bo th subj ective ly by patie nt questionnaire
and thro ug h objective vo ice parameters3 .
A econd e lement in voca l technique is the voca l warm-up.
Wa rm-up exe rc ises inc lude !retc hes of the fa ce and torso, deep
breathing tri gge r , sustaini ng vowe l o n various pitches wi th varyi ng
intens ity, humming and lip-buzzing, g lide , and the production of
con o nants. The a im of the wann-up is to max imi ze pho nati o n,
reso nan ce and respira ti on. Elli ot e t al. , hawed that voca l warm-up
red uces vi cos ity of the voca l fo lds, but that this result a lone does not
uniforml y increase ea e of phona ti on (pho nati o n thre hold pres ure)
amon g subjects 4 • It is in tead hypoth e ized that the voca l wa rm -up
affect othe r prope rti es of the voca l fold s, uc h as amplitude ,
vibrati on peri odi c ity, and nervous co nt ro l of laryngea l muscles 4 .5.
Bay loc k condu cted pre liminary resea rc h that studied the effect of
voca l-wam1 up in four ubj ects w ith vo ice di sorders6. He reported a
s ignifi ca nt improve me nt in vo ice produ ction accordi ng to acou tic
mea ures and se lf- ratin g, but noted that more studi es were needed to
co rroborate th ese re ults6 A rec urring prob lem in the li terature seem s
to be the inte r-subject variab ili ty in voca l phys iology, and the
d ifficu lty o[ findin g an adequate measure to asses the different
effects of th e wa rm-up 4•5•6 . Therefore, the efficacy of wam1 up in
vo ice di sorde rs is still inconclusive.
A third co ns iderati on in the manageme nt of any voca l di sorde r is
th e prompt treatment of secondary dysphonia . Exa mples are acid
re flux , acute laryng iti s, and a ll ergic laryng itis. One of the mo t
important c~ u ses th at sho uld be rul ed o ut is laryngop ha ryngea l re flu x
(LPR). Un hke the sto mach the larynx does not have the intrinsic
ab ility to protect from gastri c acid re lated mu co a l damage7.11 . In
add1t1 o~ to the mherent u ceptibility of the la rynx to aci d dam age,
ca rb~m c a ~h ydrase type 3 ( important in regul ating pH by producing
a lkalme bica rbonate) IS normall y present in true voca l fo ld
howeve r, dimini shed or abse nt in voca l fo ld s affected by LPR7 . The '
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symptoms of LPR include throat clearing, hoarseness, excessive
mucus, cough, globus sensation as well as laryngoscopic findings
which include posterior laryngeal edema, true voca l fold edema, and
p eudosulcus9 •11(Figure 2). The genera l approach to the treatment of
LPR is simi lar to the treatment of gastroesophagea l reflux9. Di etary
modifications consi t of limi ting foods and beverages containing
caffeine, alcohol and peppermint, which may weaken lower
esophagea l sphincter tone 11 . The ev idence surrounding the use of
PPis for the management of LPR remains somewhat inconclusive9- 11 .
However, for patients with LPR who have symptoms that impact
their profess ional or socia l responsibilities (like si ngers, actor ,
lecturers), it is recommended that treatment with PP! s be started at
high do es 11 , as well a adm ini strati on of H2 blocker and antacids
when reflux is anti cipated after meals9
In all cases of voice di sorders, a multidi sci plinary team
co nsistin g of oto lary ngo logis ts, family physicians, speec h
pathologi sts and voca l teachers are required . While speaki ng voice is
sometimes unaffected by voca l fold lesions, the reduced vocal range,
increased effort and impaired endurance experienced by professional
singers, have far greater implications to their ca reer 12. The pos ibility
of secondary causes of dysphoni a such as LPR, hi ghli ght the
significance of a thorough hi story and physical , which can revea l risk
factors and possible etiologies that lie outside the larynx . The role of
the family physician is parti cularly important in isolating and
directing appropriate treatment or referratl 4 The role of the speech
language pathologist lies in the education of regul ar speech, assisti ng
in phonati on, articu lation, respiration and resonance 12 Voca l teachers
contribute specia lized experti se in vocal hygiene, wam1 ups and
education of proper singi ng techniques, as well a profess ional
guidance. Not surpri singly, it is wide ly appreciated that combined
interdisciplinary treatment modalities support better outcomes for
patients 12-14 .
PROBLEMS FOR SINGERS: VOCAL FOLD LESIONS

Benign vocal fold le ion are common in profe sional vo ice u er .
The most likely culprit of these lesions include voca l overuse, misuse
(excess ive mu sc le tension) an d ab use (voice ove ru se o r
whi spering) 15. During any of these acts, there is excess ive
mechanical stress applied to the voca l folds. The mechanica l stres of
excess ive vi brations of the voca l fold affect the voca l fold mucosa
itself, rather than the underl yi ng muscu lature 16·17 , resulting in fatigue
damage 18. Vocal ti sue traumatized by repeated co lli sion forces,
vocal fold accelerations and decelerations, and heat di ssipation ,
which result in tissue brea kdown and remodelling 16·17·19 The
remodelling phase induces mass lesions, including voca l fold
nodules, polyps and cyst . While the histo logy and pathology of
benign vocal lesions is not fully understood, some studi es try to
correlate the different types in order to detem1ine the best pos ib le
management 15.
Vocal polyps are benign , hyperplasti c lesions of the laryngea l
mucosa. They are normall y si tuated unilaterall y20 and anteri orl y on
the vocal fold 21. It is hypothesized that voca l polyp are due to areas
of vibration-induced hyperaemia and vasodil ation resulting in
edema21 . The edema then leads to degenerati on or fibrosis21. Voca l
polyps are also associated with smoking and acid reflu x22 . First-l ine
treatment is generally regarded to be voca l behav ioural therapy' S, but
debate remains over whether patients should primarily attempt voca l
therapy measures (as in the case of voca l fold nodule ), or proceed
immediately t o s ur gica l int e r ve nti o n . A we ll-d efin e d
microphonosurgery ex ists, developed by Hochman and Zeitels,
which preserves more of the voca l fold microstructure than typical
cold instrument or laser removal22 . Stajner-Katusic et al. , in vestigated
the vocal quality of fi ve males, before, one month after and six years
after surgical vocal polyp removal. Their data showed significant
improvement of vocal quality across several voca l measures,

including elf-estimation by the participants23 . Conversely, Cohen
and Garrett showed that voca l therapy was effect ive in improving
voca l quality, by reducing the size of voca l polyp (but not
eliminating voca l polyps) in 50% of their participants, whil e the
other half required surgery 24
The response to treatment was
attributed to the polyp type. Translucent (immature, edematous)
polyps, seen by videostroboscopy, were significa ntl y more likely to
benefit from voca l therapy, when compared to fibrotic , hya line, or
hemorrhagic (matu re) polyps 24 In add ition, incomplete glotta l
closure after voca l therapy was di scussed as a potential indi cation for
surgica l referral. Without glotta l closure, ai r would sti ll escape during
si ngi ng and phonation , resulting in persistently inefficient vocal use,
sugge ting the need for aggressive treatment 24 . ln this study, longtem1 follow-up wa not performed , and there was no accounting for
differences in methodology between voca l therapists. It was
concluded that although not for everyone, there is a speci fi e patient
populati on that would max imall y benefit from voca l therapy alone,
while others should proceed directly to surgery 24
No dul es , o r " si nger ' s nodes " occ ur bilaterally a nd
symmetrica lly on the voca l fo ld and are attributed primaril y to voca l
abuse or mi suse 11 ·25 (Figure 3). Vocal fold nodul es, simil arly to
polyps, are benign areas of edema and fibrosis 25 . It is worth noting
that the difference between nodul es and polyps is not always evident,
and there is a lack of clear hi stologica l distinction 20 Vocal fold
nodules present with hoa rseness and breathiness due to a fa ilure of
the vocal folds to approx imate, pitch breaks and fat igabi li ty 25 . As
detailed above, the fir t line treatment for voca l nodul es is
behaviourall y-ba ed vocal therapy3 An interventi on review in 2009
found that there were no high quality randomized controll ed trial ,
which compared surgica l and non- surgica l interventions for vocal
nodul es 26 The article reiterates the lack of definite hi tologic
di stinction between nodules and polyps, as well as the lack of goldstandard assessment measures of voca l quality a barriers to
performing adequate trials 26 Other voca l fold pathology that is
important to rul e out by an otolaryngologist, include laryngeal
papi llomatos is, granul omas, dysplasia and carci noma, all of which
have been documented in singers as causes for voice impairment.
CONCLUSIONS

Like many other occupati onal hea lth issues, dysphonia is associated
with decreased quality of life, and may lead to loss of work in
po pul a ti o ns whose profess io ns re ly o n vocal ab ility 27
Otolaryngo logists provide a major role in both surgical and non
surgical correcti ons of nodul es that are not amenable to con ervative,
behavioural or voca l therapy treatments. Surgery was once beli eved
to be profess ional sui cide for singers a decade ago 13 , but thi s rapidly
changing perspective reflects the advances in microsurgery that have
created positive outcomes for appropriately selected patients22,24
Voice med ici ne reiterates the importance of multidisciplinary care
and combined experti se that cater to the overall goals of a particular
patient population . A always, health care profe sionals should be
aware of these modaliti es that lie outside of tradi ti onal medi cine.
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Transoral Robotic Surgery (TORS)
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inimall y invas ive surgery has revo lutioni zed surgica l
practice in the past two decades and is quickl y becoming
the tandard of care aero s multiple di sciplines. In head and
neck surgery, organ-preservation protoco ls and transora l lase r
microsurgery have laid the fo undation fo r the recent development of
transoral robotic surgery (TORS), which uses the da Vinci surg ica l
robot to orally approach the throat rather than traditi onal cerv ica l
incisions into closed neck spaces. ! The technique was developed at
the Uni ver ity of Pennsylva nia, initiall y by demonstrating wide
access to the laryngopharynx using mouth gag retractor and
perfo m1 ing procedures on a canine mode l. lin 2006, they descri bed
its appl ication in human patients fo r resection of oropharyngea l
squamous ce ll carcinoma (OPSCC).3The FDA approved the use of
TO RS in December of 2009 for resecti on of selected head and neck
tumours.2

M

The primary adva ntages of roboti c surgery in c lude the
minimi zati on of surgica l trauma, superior visuali zati on, improved
precision, and the abili ty to recreate an open surgica l experi ence .6
Additional adva ntages include better safety and morbidi ty outcomes
for the patient, which are di scussed be low.Conver ely, there are
certain di sadva ntages ofTO RS such as a confined operati ve fi e ld and
fin ancial limitations such as the high initi al cost of the roboti c system
(over a milli on dollars) and the high cost o f instruments (about one
thousand doll ars per ca e) .l However, in centers where a robotic
console a lready ex ists for genera l or uro logic surgery, adding head
and neck cases wi ll augment value of the machine and increase
prod ucti vity. I

In Decem ber of 20 I 0, Dr. Kevin Fung and Dr. Anthony N ichols
from the Department of Oto laryngo logy - Head and Neck Surgery at
the University of Western Ontario (UWO) perfo rmed the first TORS
procedure in Canada: a TO RS upraglottic laryngectomy(Figure I ).
Other options fo r the pati e nt we re e ith ero pen suprag lotti c
laryngectomy with bilate ra l nec k d issecti o ns o r full course
radiotherapy for 7 weeks (70 Gy) . With TORS , the patient was able to
avoid temporary trac heotomy and nasogastric tube (NG) fee ding, and
with negative margi ns and nodes the patient compl etely avoidedpostoperati ve radiotherapy as we ii.Thi case hi ghli ghts some of the
advantages of TORS fo r the treatment of head and neck cancer,
which wi ll be discussed fu rther below a long with detail s of the
procedure and future directions.

SURGICAL PROCEDURE
The Da Vi nci surgical platfo rm consists of a conso le, a surg ical
cart, and a manipul ator unit. The TORS procedure in vo lves the
transoral inserti on of two wri sted instruments anns and a central 3D
endoscope.4 The console offers the surgeo n a three-dimensional
magnifi ed view and allows control of the twoendowristed roboti c
anns, whi ch he lps to enhance manual dexterity.5 The system a ll ows
for the surgeo n's hand movements to be motion-sca led and thereby
eliminates physiological hand tremor. 6
The first clinica l use of the Da Vinci robot fo r head and neck
surgery involved the remova l of a benign oropharyngeal lesion and a
thyroidectomy. 7,&Applications have expanded to procedures such as
parathyroidectomy and skull ba ed surgery.9, I OHowever, the main
application of TORS is in the treatment of ma lignancies caused by
squamous cell carcinoma (SCC) which can invo lve the oral cav ity,
oropharynx, hypopharynx , and larynx .6Such cases include TORS
tonsillectomy, TORS tongue base resection, and TORS supraglotti c
laryngectomy.

Figure l. Dr. Anthony N ichols (left) and Dr. Kevin Fung (right) fro m
the Department of Otolaryngo logy - Head and Neck Surgery at the
Uni ve rsity of Western Ontario,standing next to the control console of
the Da Vinc i surgica l robot.

OUTCOMES
Due to its relati ve in fa ncy, there are currentl y no contro ll ed studies
comparing TORS procedures to their open surgical counterpart or
primary chemoradiation for the treatment of oropharyn gea l cancer.
However, di ffe rent case series of pati ents who underwent resection of
oropharyngeal squamous cell cancer (OPSCC) by TORS show
pro mi sing re ults and highlight several advantages .
SAFETY
No major complicati ons and acute seque lae of TORS have been
re po rted . Min o r co mpli ca ti o ns in c lude tran so ra l blee din g,
exace rb a ti o n of s lee p apn ea fro m posto pe ra ti ve we llin g ,
development of moderate tri smus, and temporary hypem asa lity of
voice. lin genera l, patients who undergo TORS have lower estimated
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blood loss (<200 mL) when compared to open surgery, and none
ha ve required blood transfusions. ! TORS patients a lso have a shorter
ho pita! length of stay, as most are di scharged six days after OP CC
re sec tion .3 ,4ln co ntr as t , patient after ope n s upr ag lottic
laryngecto my wou ld typically stay I 0-14 day in ho pita! postoperatively.

ONCOLOGICAL
OP CC re ection with negati ve margins in a ll patients was reported
by different ca e series ranging fro m 12 to 45 patients.4, II , 14- 16 For
example, in the case se ri es from the Mayo c linic, a ll 45 patients with
ei ther ba e of tongue or tonsillar fo a tumors had negative margi ns
after TORS resection, and 12 were able to avoid adjuva nt radi ation .
II A recent publication from the Univer ity of Pennsylvania reports
that, out of 50 cases, 2 patients developed distant metasta es and one
patient developed both loca l and di stant recurrence of di ease
following TORS resection of OPS
(mean follow-up : 2 yea rs).
19More long-term onco logical outcomes are unava ilable at thi s time.

FUNCTIONAL
Pre erving airway and swa llowing fun cti o n is a n important
determinant of quality of life followin g oropharyngeal surgery, and
large ly depends on whether the patient receive po !-operati ve
radiation or chemotherapy. To date, none of the four patient trea ted
with TORS at UWO have required adju va nt radiation therapy a th ey
al l had negati ve margin and nodes po t-surgery (negative nodes
weredetermined by patholog ical stag ing of a taged nec k di section
two weeks post-TORS). In the event that patients do have positi ve
node , th e adj uvant rad iation do age needed (60Gy) will be smaller
than primary radiation treatment (70-72Gy), minimizing s ide effects.
At other centers, reported rates of temporary tracheotomy in
patients who undergo TOR range from 3% to 31 %, with an average
time to decannulation of even days.4, II , 15The use of Gtube for
enteral feeding shows greater va riance due to surgeon and center
preference. In a case se ri es of 45 patients at the Mayo clini c,
Gtubes were used in 48% of patients, with a mea n durat ion of 12.5
day .4 In another case erie of 18 patients at the Mount S inai choo l
of Medicine, no feedingtubes we re used and patients were fed a
pureed di et one day after urgery. I4These data suggest an advantage
over primary chemoradiat ion , w he re 17-30% pati e nts a re
gastrostomy-tube dependent after one year due to dysphagia 18, and
open surgery, where all patients are typ ica ll y kept on NG tube for
several weeks due to a pi ration ri k.

FUTURE DIRECTION
With th e increasing popularity of ro boti c surgery, training guid e line
and opportunities mu t be developed fo r curre nt practitioner lookin g
for ce rtifi cation . Similarly, a more re idency programs acquire robot
access, standardization of res ide ncy and fe ll ow hip curri culum w ill
a lso be important. Currently, a ll Head and Neck Surgery fellows
graduating from the Un ive r ity of Penn ylvania are trained in TOR .
I The university also run s a TORS tra ining program for surgeo n
from arou nd the world .
As surgeons become more comfortab le with TORS , new and
innovati ve procedures are being deve loped as well. One exa mpl e is
transax i ll ary thyroidectomy, w here the th yroid g land i removed
without ha ving to c rea te an unaesthetic cervica l sca r. The procedure
was deve loped in Korea and has been pe rformed in over 300 patients
a of2009.17

from case series uggest possible benefit of TORS over primary
chemoradiation at preservation of wallowing function after resection
of o roph aryngea l tumours. This offersa very ad_vantageous quality of
life consideration, especiall y for the increasmg mctdence ofOPSC~m
you ng HPV-posi ti ve pati ents. l9 However, long-ter_m o ncolog tcal
outco mes of oropharyngeal cancer afterTORS resection are not yet
ava ilab le, and further tudies a re warranted .
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CONCLUS IONS
TORS is a safe and minima ll y invasive surg ical tec hniquewith
many ap plicati o ns in head and neck urgery. Benefits of TORS over
tradi tional ope n surgery inc lude hand tre mor redu ction , better
visuali za tion , and minimization of surgica l tra uma. Promi s ing data
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n estimated 644,000 cases of head and neck ca ncer are
di agnosed wo rldwide each yea r, w ith head and neck
squam ous cell carcinoma (HNSCC) acco un ting fo r over 90%
of these. Common presenting s ites inc lude the ora l cav ity,
oropharynx, nasopharynx, hypo pharynx , and larynx. I While chronic
tobacco use and alcohol consumption are well -establi shed ri sk
facto rs,2 human papillomav irus (HPV) infection of the upper
aerodi gestive tract has been cau a ll y li nked to tumori genesis.3 In
particular, the increasing rates of oropharyngea l cancers, especiall y
young non-smokers, has been directl y attributed to HPV infect ion.

A

The diagnostic workup of HNSCC typicall y incl udes history
and physical examination, endoscopic-guided biopsy and highreso luti on co ntras t-enh anced co mputed to mogra ph y (CT ) o r
magnetic resonance imaging (MRI). Whil e CT and MRI have
traditionall y been the cornerstones of the imaging workup, 2-fluoro[ 18F] -deoxy-2-D-glucose positron emission tomography (FDG- PET)
plays an increasing ro le in the diagnosis, rag ing and fo llow-up of
HNSCC patients.! ,4,5

FDG-PET AND PET/CT IMAGING
FOG, a glucose ana log labe ll ed with the radi onuc lide 18F,
preferentiall y accumu lates in cell s that have an increased g lyco lytic
rate - a characteri stic fea ture of cancer cell s.6 FDG-PET is thus a
fu nctional imag ing modality that detects cellular metabol ic changes,
unlike CT and MRI , which re ly on stru ctura l abnorma litie . The
positrons emitted by the radi onuclide an nihilate nearby electrons and
create photons that are captured by an array of detectors and
reconstru cted into a 3D image. A lthough PET a lone is limited by its
lack of anatomic localizati on, the advent of the hybrid PET/CT
scanner has overcome thi s by fu sing PET and CT images acqu ired in
a single session, permitting deta iled visualizati on of both structu ra l
and fun ctional aspects of di sease. I ,4-6

STAGING OF HEAD AND NECK CANCER
TNMSTAGING

PRJ MA RY T UMOUR
Whil e PET and PET/CT have been shown to be at least as effecti ve
as CT or MRI at detecting primary tu mours, these modalities are not
used in ta ndard practice to T- tage new ly di agnosed HNSCC
because their anatomic reso lution is not as hi gh as that of MRl or
contrast-enhanced multi slice CT.9- I 3 An earl y tumour may have
poor FOG uptake and its detection on the scan may be obscured by
cross contamination of physiologic acti vity from surroun d ing ti ssues
- the so-ca ll ed 'spill over effect' . l 4 CT and MRI are usefu l fo r initia l
T-staging, since the ir high spat ial resolution and soft-tissue contrast
can demonstrate subtle abnorm aliti es and acc urate ly de lineate
tumour volume.

CARCINO MA OF UNKNOWN PRIMA RY
In 2-9% of patients with new ly di agnosed HNSCC, cervica l node
metastases are clinicall y ev ident at bi opsy but the primary tumour
cannot be identifie d by conventi ona l workup, which includes
phys ica l examination, CT, MRI and endoscopic-guided biopsy. l 5
PET/CT has proven to be sign ifi cantly more sensitive than CT (94 .0
versus 7 1.6%, respecti vely, P < 0.00 I) at detecting carcinomas of
unkn own primary. l 6 Rusthoven et al. reviewed 16 studi es published
between I 994 and 2003 and found that among 302 patients with a
negati ve conventional workup, FOG-PET detected the primary
tumour in 74 patients (24.5%). 17 In a more recent review, A llbraheem et al. performed a meta-analys is of 8 stud ies publi shed
between 2000 and 2009 .5 FOG-P ET or PET/CT were ab le to detect
the unkn own primary in 5 I of 180 patients wi th an otherwise
inconclu ive workup . Delineation of a pri mary tumour i e sential fo r
delivering targeted therapy, minimizing therapeutic morbidi ty caused
by wide- fi eld irrad iation and improving prognosis. IS A recent report
noted that findin gs made by FOG- PET changed therapeuti c
manage ment in 25% of pati ents. l 9 In light of th is evidence, PET/CT
may have an important ro le in the di agnosti c assessment of
carcinoma of unkn own pri mary.5

CE RVICAL NO DE METASTASES

HNSCC is staged acco rdin g to the size and extent of the pri mary
tumour (T), regional lymph node involvement (N) and the presence
of distant metastases (M).4 Accurate stag ing at the time of di agnosis
is the most important fa ctor for pl a nning manage ment and
determining prognosis.4,7 Since the preservation or restoration of
fu nction is a top pri ori ty in the management of patients with HNSCC,
fu ncti on-sparing strategies such as minimall y invasive surgery or
(chemo)radi otherapy are often considered as fi rst- line treatments .&
Thorough clinica l assess ment, including imaging, is vita l to optima l
staging of HNSCC. Furthermore, re-evaluation of patients fo llow ing
treatment may be especiall y challeng ing in HNSCC, due to difficul ty
in obtaining pathology. The fo ll owing subsecti ons rev iew the c li nica l
indications for FOG-PET and PET/CT in staging HNSCC.

Cervica l node status is the most important prognosti c factor in
HN SCC.7 Cure rate declines by nearly 50% when cervical
metastase are present.20 Metastatic lymph nodes are found in
approxi mately half of patients at the time of di agnos is.2 1 PET/CT
has been shown to have better sensiti vity and specificity for
patho logic cerv ica l nodes than MRI and CT, like ly because the latter
rely on nodal size and contrast-enhancement criteri a w hich are not
specific and can miss metastase in norm all y sized nodes .22 ,23
Neverth eless, CT is generall y used for loca l staging of clinicall y
mani fes t cerv ica l nodes at initial di agnosis, due to its c linical
ava ilability and accurate T-stag ing of the primary tumour.
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CLINICALLY NEGATIVE (NO) NECKS

l f clinica l examinati on fa ils to identi fy metastati c cervica l lymph
nodes in pati ents with primary HNSCC , these pati ents are sa id to
have a clinica ll y negati ve (NO) neck. Since th e probability that th ese
pati ents actuall y have a pathologica l neck vari es between I 0-45%,
electi ve neck di ssection is recommended in cases whe re the ri sk of
occult cervical mets is greater th an 20% .4 While PET/CT is th e most
acc urate imaging modality for detecting occult metastases, the role o f
PET/CT in the asse sment of NO necks is still controversial. ?
Microscopic di sease or nodal metastases located adj ace nt to th e
primary tum our may evade radiographic detection and contribute to
fa lse-negati ves. Two studi es reported sensitivity and specifi city
ranging from 67-79% and 82-95%, respecti ve ly, leadin g the auth ors
to conclude that PET/CT is not yet accurate enough to inform the
need for surgical di ssecti on in cases of occult nodal disease.24,25
SECOND PRIMARY (SYNCHRONOUS) MALIGNANCY AND
DISTANT METASTASES
Pati ents with adva nced HNSCC are at hi gher ri sk for deve loping
dista nt metastases and for prese ntin g with a second primary
(synchrono us) tumour;26 the latter being defin ed a a hi sto logica ll y
distinct malignancy, se parated from the primary tumo ur by at least
2cm of normal muco a.27 The cost of mi ssing distant metastases o r
synchronous tumours at the time of initial di agnosis is hi gh. C urati ve
therapies a re ofte n assoc ia ted w ith s ig nifi ca nt mo rbidit y,
necessitati ng the careful se lecti on of patients with nonmetastati c
di sease who may benefit from the treatment and not eve ntuall y
succu mb to previo usly undetected di stant di sease .28 Aggressive
subtypes, such as naso pharyngea l carcinoma, have a tendency to
metastas ize to the lungs, li ver and bone; hence, th e conventional
imaging workup fo r di stant metastases is comprised of chest
radi ograph y, abdominal ultrasound, and skeletal scintigraph y (bone
scan). Several reports have assessed the efficacy of P ET/CT in
staging di stant metastases and sync hronous tumours and found that it
is the most sensiti ve, spec ific and acc urate modali ty and may repl ace
conventional tec hniques. l4,28,29 A multicentre prospecti ve study of
92 pati ents fo und th at PET/CT had a hi gher ensiti vity (63%) th an
chest CT (37%), due to its ab ili ty to image the whole body with a
single scan a nd detect di sta nt hypermetaboli c foc i.3 0 PET/CT can
therefore be considered as th e moda lity of choice for the di agnostic
workup of di stant metastases and sy nchro no us tum ours.7
RESIDUAL AND RECURRENT DISEASE
The reli ance o f CT a nd MRl o n morpho logic c riteri a often makes th e
detecti o n of post-treatment residual tumo ur acti vity or recurre nt
disease diffi cult, since the regiona l head and neck a natom y may be
di storted a fter th erapeuti c (chemo)radi oth erapy and/or urgery.4 Allbraheem et al. rev iewed th e utili ty o f PET and PET/CT for

identi fy ing disease recurrence in head and neck cancers.5 Among 7
studies published betwee n 2004 and 2009, PET or PET/CT
de monstrated hi g h sensiti v ity (83 -1 00%) and relatively h1gh
specificity (78-98% ) and accuracy (~1-90%~, oft~ n significantl y
outperformin g CT a nd MRI. InflammatiOn and mfe~t10n are common
treatment sequel ae that may increase FDG uptake_m certam . tissues;
hence the addition of CT to PET is espec1ally Important m these
situat{ons in o rder to distingui sh trul y patholog ic areas from postirradi ated ti ss ue. l2 ,22 The anatomica l landmarks provided by CT
have bee n s h ow n to d ec rease the number of equivocal
hypermetabo lic foci a nd there fo re reduce the amo~ nt non-in vas ive
imaging and in vasive biopsies required for d1agnos ts of recurrence.
12
LIMITATIONS

F a/se-positives
In additi o n to the post-irradi ati on cha nges di scussed above, increased
FDG uptake may occur in benign hyperpl astic conditions such as
th yroid or pleomorph ic adenomas . Regiona l physio logic FDG uptake
in lym pho id ti ssue, ali vary g la nds, strained o r excessively used
skeleta l muscles a nd activated brown fa t ti ss ue may a lso confound
interpretation and be e rro neously attributed to malignancy.4,6 It is
recom mended that positi ve res ults be conflfllled by biopsy.6

False-negatives
Since the patial resolution of FDG-PET is limited to 4-1 Omm, it
ab ili ty to precisely loca li ze sma ll tumours or microscopic tissue
involvement is often dimini hed in the head and neck regi on.
Tumours with low meta bolic rate and poo r avidity for FDG uptake
may also be diffi c ult to c haracterize on PET scans.6
SUMMARY AND RECOMMENDATIONS
In 2009 , Yoo and Walker-Dilks reviewed th e data and made
recommendati o ns for the use of FDG-PET in head and neck cancer.
3 1 The gu idelines, part of an initiative of the Program in EvidenceBased Care for Cancer Care Ontario, are consistent with the findings
reviewed here and are summarized in Tab le I . It is worthwhi le to
note that studi es examining PET and PET/CT were not distinguished
in th e report; however, th e hybrid syste m clearly confers a di agnosti c
adva ntage over either modali ty alone.4-7 De pite its limitations,
increa ing use of PET/CT for th e diagnosis, stag ing and follow-up of
HN SCC pat ients ha pro vided phys icians with a powerful tool that
will continue to improve patient outcomes as the technology
advances and clinica l guideline are re fin ed .
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s of 2003 , 40% of Ameri can aged 12 yea r and older had
smoked marijuana at least once. 1 Approximately 30% of
Canadi an yo uths from G rades 7-1 2 have tri ed cann abi s at
least o nce.2 Marijuana is the most widely-used illicit substance in
Canada, with l 0.6% of th e Canadi an popu lati on reporting u e in
2009 .3 Thi s is si milar to th e US annu al fi gure of9%. 4 Global reports
indicate that th e ave rage age o f first marijua na use is decreas ing,
even as the average delta-9-tetrahydrocannabinol (TH C) content of
cannabi s is on th e rise. This may lead to an increase in both addi cti ve
pote ntial and adverse effects of marijuana use.5

A

A survey of the adult US populati o n comparin g fi gures from
1992 and 2002 suggested that th e prevalence of mariju ana use
remained stable over th e decade, but the prevalence o f marijuana
dependence increased significantl y. T hi s increase in marijuana use
disorders has occurred in th e absence o f increased frequency or
quantity of marij uana use, suggestin g that the enhanced potency of
TH C may have lead to the rise in rates 6 Treatment admi ssions fo r
cann abi s abuse have ri sen steadil y over the past ten yea rs, including a
2-fold increase in the US and 3-fold increases in Australia and
Euro pe.7
Although publi c perceptio n remains th at cann abi is "so fter" and
less dangerous th an oth er illi cit substances, cann abis use is becomin g
a majo r publi c hea lth concern ; some research even sugge ts it may
serve as a gateway dru g to " hard er" substances.s Furthe rm ore,
mul tipl e studi es have show n an inc rea ed ri sk in marij uana users of
oth er long-tenn hea lth conseque nces . In thi s paper, we review c urrent
research and und e rstandip g of ma riju a na's impact o n hea lth
outcomes. We also prov ide an overview of at-ri sk popu lati ons for use
and ab use of marij uana, summari ze mariju ana' potenti al positi ve
e ffects, a nd di sc uss implicati o ns fo r hea lth pro moti o n and va ri o us
levels of preventi on.

PULMONARY EFFECTS
N ume rou s studi es have shown th at the combusti o n of tobacco and
marijuana produces simil ar hannful compo und .s,9 T he ri sks of
mariju ana may be increased by three facto rs. Mariju ana smoke has
three times more ta r and 1.5 times mo re carcinogeni c substances th a n
tobacco smoke. 10 Marijuana smoke is typi ca ll y inhaled mo re deeply
and held in the lungs longer: the re is more time for depos itio n of
parti culate matter. Furtherm o re, marijuana ciga rettes do not conta in
th e same filter apparatus as conventi onal to bacco ciga rettes. On th e
oth er hand, even heavy marijuana use invo lves far le s smoke
inhalation th an th e equi va lent a mount o f tobacco in a pac k-a-day
smoker. One analy is of 19 previo us studi es defin ed marijua na use
as smokin g I 0 or more ma rijua na ciga rettes per week for 5 or more
yea rs. 1 One pac k o f tobacco ciga rettes contains 20-25 ciga rettes, and
th e cigarettes ge ne rall y contain more combustib le mate ri al th an their
mariju ana co unterparts.
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Smo ke - wheth er fro m ma riju ana, to bacco or any other combustible is noxio us to the airways. Thi s stimulates sho rt-term bronchitic
reacti ons, including coug hing, sputum producti o n and wheezing. In
tum , th ese activate th e mucocili ary esca la to r, w hi c h carries
parti culate matter fro m th e bronc hi c ra niall y to be ex pectorated or
swall owed.
O ne systemati c rev iew fo und th at inhaling marijuana smoke can
ca use clini cal dyspnea and pharyng iti , as we ll as exacerbating preex istin g pulmonary illnesses suc h as asthma and cysti c fibrosis; these
effects persi ted after adju ting fo r conc urre nt to bacco use. 5 Despite
these apparentl y harm fu l effects, th e review fo und no a sociation
between mariju ana smoke inhalati o n and effects o n FEY I (forced !second ex piratory vo lume) or FVC (fo rced vital capac ity), DLco
(diffusi ng ca pac ity of the lung of carbon mo nox ide) or airway
hype rreacti vity. T he auth ors ex plained these findin gs by sugge ting
th at cann abinoid pro mote the T h- 2 anti-infl ammatory immune
response while ni cotine suppres es it. O ne stud y noted that the use
of a vapo uri ze r when consumin g marij uana was associated with
dec reased respiratory sym ptom . 11 A va pourizer is a device that
heats the marijua na to th e va po ri za ti on point of the cann abinoids
witho ut the use of fla me, thereby o bv iat ing th e consequ ences of
smoke inhalati o n. Altho ugh the re are ma ny confo und ers in these
analy es, not the least of which is th e fac t that many marijua na users
cut the dri ed mariju ana w ith commerciall y-ava ilable to bacco, it can
be concluded that smok ing ma riju ana exacerbates pre-ex i ting
res pira to ry co mpl a ints by directl y irritatin g th e res pira to ry
epithe lium . However, contrary to to bacco moke, ma riju ana smoke
does not seem to ca use ob tructi ve pulmo nary di seases.

LUNG CANCE R
The _extant_ litera ll.~ re on mariju ana and lun g cancer presents
co nfl1 ctm g mfo rm atl on. On the o ne hand, marijuana smoke contain
benzopyre ne, a carcinogeni c hydrocarbon also fo und in tobacco
smoke, which has bee n _implicated in mutati o ns related to lung
cancer. Ex pe nmenta l tud1 es have also demonstrated THC-induced
ma lig nant cell pro life rati on a nd sugges ted tha t THC inhibits
antitumo ur immunity, thu s promotin g tumor growth. In contrast,
othe r v1tro m ~de l s suggest that cannabinoid may actua ll y exhibit
ant1 carcmogen1 c effects. 12 In a n attempt to reconc ile these di veraent
streams o f tho ught, Mehra, Moore, C roth ers et al. undertook a
syste mati c review to detennine the associations between marijuana
mo kmg a nd lung cancer incidence, -~i sk fa cto r , or pre malignant
1
changes. The a uth or found that manJuana smokin g bas increased
tar de_h ve~ ~o lungs compa red with ciga re ttes, and marijua na smoke
conta ms s1mdar carc inogen as tobacco smoke, o ften in inc reased
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concentrations. Marijuana smoking was associated with the presence
of more metaplastic cells, impai red alveo lar macrophage function ,
and increased oxidative stress w hen compared with non-smokers. Six
studies included in the systematic review reported hi stopatho logic
and molecular findin gs from bronchi al biopsy; in a ll studies,
marijuana smo kin g was a soc ia te d with a bn o rm a l a nd /o r
precancerous alterations when compared with e ither non-smoker or
tobacco smokers. One study in particular reported an additi ve effect
between marijuana and tobacco use. All the e findings suggest a
biological plausibility for the association between marijuana use and
lung carcinogenes is. However, a cohort stud y of 65,000 subj ects
showed no increase in lung cancer incidence in marijuana smoker
after contro lling for tobacco use. The authors suggested that there
may be methodological concerns underpinning the lack of empiri ca l
support fo r increased lung cancer incidence in marijuana users,
including the need fo r more detailed assess ment of marijuana
exposure and longer follow-up periods. They a lso cautioned that
physicians should still advise their patients of the potentia l adver e
health effects of marijuana use, including premali gnant lung changes .
I

While methodological factor may we ll account for the lack of
evidence for an association between lung cancer and marijuana use,
Melamede 13 ha summarized another line of thought: although
marijuana and tobacco smoke contain s imilar carc in oge n ,
cannabi noi ds and nicotine present with very different cellul ar effects.
Firstly, although low-doses of THC may indeed promote tumour
growth, the response appears to be biphas ic; a ltern ate doses of
cannabinoid have been capable of destroying cancer cells (including
lung, breast, prostate, skin, and g lioma) in vitro and in anima l
models. Secondly, both nicotine and cannabino id receptors are linked
to signaling pathways that can tum on anti-apoptosis (i.e. preventing
cell death). Nicotine receptor are fo und in respiratory epithe li al
cells, whi le cannabinoid receptors are not. As such, when nicoti ne
receptors are stimul ated in res piratory cell s, there is an anti-apoptotic
signal; the prevention of cell death under ex posure to such mutage nic
conditions (i.e. smoking) is likely to amplify carci nogenic potenti al.
Thirdly, while nicotine promotes neovascul arization and thus tumour
growth, cannabinoids inhibits angiogenesis and results in tumour
regression. Finally, the introduction of partic ulate matte r and
carcinogens into the respiratory system res ults in the creation of a
pro-inflammatory state. In this ci rcumstance, cannabino ids redu ce
the associated free radical production by dri ving a re lative ly anti inflammatory Th2 immune cytoki ne profile. Melamede suggests that
all these critica l facto rs can ex plai n the lack of association between
cannabis use and lung cancer. 13
Even in light of this controversy surroundin g cannabino ids and
their association with lung carci nogenesis, Guzman has go ne so far
as to suggest that cannabino ids could be used to deve lop novel
anticancer therapi es. 14 In additi on to evidence uggesting inhibiti on
of tumour growth, marijuana may a lso be beneficial to chemotherapy
patients- it has the potentia l to miti gate nausea, vom iting, and pa in
while also sti mulating appeti te.

NEUROPSYC HOLOGICAL EFFECTS
Aside from its respiratory and pulmonary effects, marijuana use has
been associated with neuropsycho logica l consequences. C hroni c
marijuana use has hi storica ll y been associated with impaired
cognition, including reduced attention, memory, higher cogniti ve
function (e.g. executi ve function) and psychomotor defi cits. One
study showed that after 25 days of abstinence, moderate (8-35
marijuana cigarettes/week) and heavy (53 -84 marijuana cigarettes/
week) users had decreased activity in the ri ght latera l orbitofrontal
cortex and the right dorsolateral prefrontal cortex, and increased
activity in the left cerebellum, compared to the contro l group, during
a decision-making game . 15 Another imaging stud y, using transcranial

Doppl er sonography, showed increased cerebrovascu lar resi tance in
chroni c li ght to heavy users. 16 However, these studies were small ,
with II and 54 su bj ects, respectively. One meta-analysis of tudies
tota lling 623 chron ic marijuana users fo und that a lthough these
indi viduals may show decreased ab ili ty to learn and remember new
inforn1 ati on in the long tern1, other cogniti ve proces es were
unaffected.
Thus, while there may be neurophysiological and
neurovascul ar effects of chronic marijuana use, some of these effects
may be sil ent.
Marijuana use has been shown to have negative psycho logical
conseq uences, specifica ll y an increased ri sk of psychosi . It is
poss ibl e that cannabino ids ' effects on dopam ine release contribute to
the onset of psychosis. 17 A ystematic rev iew of 35 popu lation-based
longitudinal stud ies concluded that individuals who had ever used
marijuana had an increased risk of developing p ychosis later in life.
18
Furthermore, a dose-dependent relationship was observed w here
heavier users had a further increased ri sk of psychosis (adj usted OR
1.41 , 95% CI 1.20- 1.65 vs. 2.09, 1.54-2.84 , res pectively) . Of course,
a possible interpretat ion of these re ults is that an underl ying,
undi agnosed psychotic disorder leads to cannabi s u e, which
faci litates the di scovery of the pre-exi ting psychological illness.
Simil arl y, the oft-c ited 'amot iva tional syndrome,' in which the
sufferer is chronica ll y unprodu cti ve, a imless and unmoti va ted, is
One study found that
assoc iated with chronic marijuana use.
indi viduals who have used marijuana a minimum of 5000 times were
signifi cantl y less likely to graduate from co llege and less likely to
earn more than $30 000 (US) per year. 19 However, like psychosis,
thi s may be expl ained by the presence of many confounders
inc luding pre-ex isting depression. Gruber et al. have recently
published data indicating significant alterations in fronta l white
matter tracts in chronic marijuana smokers. The authors suggest that
these changes are associated with increased impulsivity, whi ch may
contribute to the initiation of chroni c marijuana use or the inab ility to
di scontinue use20

HEALTH PROMOTION
Risk factors for marijuana use and abuse: Ri sk factors for
marijuana use include male gender and age 18-25 , while risk fac tors
for dependence, defi ned a a maladapti ve pattern of use despite
negati ve effects, increa ed use, unsuccessfu l attempts at cessation
and phys iologic withdrawa l, include ma le gender, age 12- 17 and
absence of post-secondary edu cati on 4 Stinson et a l. 2 1 ha ve
underscored that cannabi s abuse and dependence are genera lly
phenomena of ado lescence and youn g adulthood, and onset of
dependence after age 30 is rare. Stinson et al. 's results confirmed
that, unlike w ith alcoho l (where ri sk of dependence persists for
decades after first use) , there is a shorter developmenta l peri od of
risk for cannabi s dependence. As such, there is a window of
o pportunity in ea rl y ado lesce nce for the impl eme ntati on of
preventi on and intervention programs, in order to have max imum
impact. A pro pecti ve long itudinal study of a community sampl e (n =
302 1) aged 14-24 years in Munich, Gennany,22 found that 56% of all
repeated cannabi s users (five times or more) still reported cannabi s
use at 4-year fol low-up . At 10-yea r fo ll ow-up, thi s proportion had
decreased onl y sli ghtl y to 46 .3%. Among youth who are repeated
cannabi s u er , patterns of use remain table, and rates of cessation
are low, until age 34. Such patterns suggest that preventi ve measures
sho uld de lay first use and reduce the number of uses, as these factors
appear cruc ial in the transition to persistent and dependent use of
cannabis.22
A lthough males may have hi gher rates of marijuana use, Schepis
et a l. 23 have suggested , based on results from a cross-sectional survey
of Connecti cut ado lescents, that fe ma les may have a more rapid
tran ition from initi al marijuana use to regul ar or dependent use. The
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authors also suggested that marijuana use was assoc iated, not
surprisingly, with ri sk behaviour parti cipation (e.g. other substance
abuse) and that partic ipati on in ex tracurri cular activities was
protective agai nst marij uana use. A prospective cohort study of Swiss
teenagers and youn g adu lts was performed to evaluate different
lei sure time acti vities and the persons (e.g. partn er, friend, si bling)
with who m the acti vities we re undertaken 24
The choice of
compani ons for leisure act ivity was mo re important than the activity
itse lf as a predi ctor of initi ati on and progressio n of cann abi s use,
supporting the widespread view that peer influences are parti cul arl y
important in you ng people's risk behaviour . This finding was
rei nforced by data from the German study 18 cited above, in whi ch
peer use of cannab is, stressful life events and alcohol depende nce
predi cted long-term mariju ana use.

Treatment of marijuana use disorders: Despite public perceptio ns
of marijuana as a relative ly innocuo us drug, exposu re. to
ps yc ho ac ti ve ca nnabinoid s can indu ce st ro ng drug- seek mg
behaviours; these are medi ated by increased dopamine release m the
brain 's reward pathway.29 Abrupt w ithdrawa l of canna bm01ds after
long-term ex posure can produce dysphoric effects, wh1.ch ~ay
contribute to relapse. Although cannabis shares neurobwlog1cal
features associated with de pe nd e nce o n o th e r dru gs , on ly
approximatel y one-tenth of individuals who abuse cannabi S had ever
rece ived treatment. 17 Psychosocial interventions, although effect1 ve
in the short-term, often lead to long-term relapse, and the ava tlable
beha vioural treatments are onl y modestly effective. As such, there IS
a need to develop pharmaco logical intervention , and currently none
have been va lidated throug h clinical trial s.25

Marijuana and tobacco: Health promotion for marijuana cessation is

As described above, cogniti ve impairments may not be fully
reversible even I month after cessation of marijuana use. It re mains
un clear if these findings refl ect long-term effects of marijuana, or
si mpl y an impairment of baseline cogniti ve functioning in marijuana
users. Nonetheless, cogniti ve impairments in marijuana users may
result in poor treatment response,3° particul arl y in light of the lack of
motivation and increased impu lsivity that is assoc iated wi th c hro nic
marijuana use. Studies have suggested that c ho linesterase inhibitors
may ha ve a ro le in improving cann ab is- indu ced cognitive
impairments, but these drugs have not yet been evaluated in humans
for the treatment of marijuana dependence. Cogniti ve re habilitation
has improved function an d treatment outcomes in individuals
addi cted to oth er drugs. ofuoglu et al. have thu suggested that
improving cogniti ve function may serve as an important treatment
strategy for marijuana use disorders 2 6

pa rti c ul a rl y importa nt g ive n the hi gh co-m o rbidit y between
mariju ana and tobacco use, and the potentiall y damag ing interact ion
of these two ubstances on respiratory outcomes. Leatherdale,
Hammond, Kaiserman et at.2 5 described results fro m a 2004 tobacco
use survey of 20,000 yo un g adu lt Canad ians (aged 15-24). The rates
of marijuana use were hi ghest among current tobacco smokers, and
lowest a mong yo uth who had never smoked.
Those who use
marij uana are less likely to quit smoking (odds rati o 1.94); th ose who
use marijuana dai ly are even less li ke ly to quit than th ose who have
used at some point in the past 30 days 26 Thus, whil e marijuana use
itself may or may not be assoc iated with an increased ri sk of lung
cancer, marijuana use may secondaril y increase th e ri sk of lung
cance r throug h its assoc iati o n with pe rsistent to bacco use .
Conve rsely, through use of prospecti ve survey meth odology, Schaub
et at.2° found that nicotine use increases the ri sk for both the
initiation and the progression of cann abi s use. The auth ors also
repo rted that tobacco use remai ned hi gh even afte r reduction or
cessati o n of cannabis use. Thus, there appea rs to be a bidirecti ona l
ri sk between tobacco and marij uana use, with use of either substance
increasing the likelihood of using the oth er. Clini cians should ask
about marijuana hi story and take marijuana use into account when
recommending tobacco smoki ng cessati on meas ures for th e ir
patients, and vice ve rsa.

Mental health disorders and use of cannabis: A study of 884 1
Australian adults aged 18- 85 year found that participants wi th
affecti ve disorders and anxiety di sorders were at increased ri sk of
harmful drug use and drug dependence. 27 This corre lati on was
parti cul arl y strong for you ng males, a group already identified ea rli er
as hi g h-ri sk for ma rijuana dependence. Another stud y reportin g o n
cannabis use disord ers and mood and a nxiety disorder co-morbidity
showed th at bipolar diso rd ers, pa ni c disorder with ago raphobia, and
generali zed anx iety disorder had th e stro ngest associa ti o ns wi th
cann abis abuse and dependence. 17 Whi le th e directi o nality o f thi s
assoc iati on re mains un clea r, one th eory is th at th e ex peri ence of
untreated affective disorders and anxiety disorders may lead to se lfmedi cati on with psychoactive substances such a mariju ana. A uc h,
it is important for hea lth practitioners to identi fy a nd treat und erl yi ng
men tal hea lth conditi ons in a timely and effective manner. Indeed,
there is evidence th at such practi ces can reduce ma rijua na use, as
demonstrated by two ra ndomi zed controll ed tri als included in a
systemati c rev iew.28 For exampl e, in a flu oxetin e treatment gro up,
ca nn abi use decreased in patients with depression. In patients with
psychoti c disorders, both olanza pine and ri sperid one treatment
grou ps also reduced cannab is use. From a health system-level
perspecti ve, overcoming th e treatment fragme ntati on between mental
health and drug and alcohol serv ices wo uld mea n that the iss ue of
comorbidity among clients (particularly yo un g peopl e) can be more
adeq uately addressed.7

34

Harm redu ction through use of va po uri zers : Given the
widespread use of marij uana, th e increasing abuse a nd depende nce
on this sub tance, and the paucity of effective treatment trateg ies, it
is important to consider harm reducti on approaches to mitigate
marijuana' potential adver e con eq uences. This pragmati c approach
is parti cul arly com pelling given marijuana 's increasing use for
medi cinal purpo es. Accord ing to resu lt from a 1998 Canadi an
survey, medi ca l use of marij uana was less common than its
recreati o nal use (2% ve rsu 7%),31 but thi picture may change in
light of the shi ft ing legal la ndscape surrounding medic inal marijuana.
Cann abinoids acti va te the arne neu rotra nsmitter pathways as
e ndocannab inoids, prod uci ng effects ranging from a nalgesia to
appetite stimulati o n to nausea reduction . They al o cau e a reduction
of intraocul ar pressure, hence the usefulnes of ma riju ana in treating
the ymptoms of g laucoma.32 The main challenge for the medi cal
u e of cannab ino ids is the deve lopment of safe and effective methods
of use th at lead to therapeutic be nefi t, without res piratory
conseq ue nces o r oth er adverse effects.
Ea rl eyw ine a nd Ba rnw e ll 11 ha ve desc ribed th e use of
vapo uri zers among marij uana smokers : vapo uri zers release active
cann a bino ids but not smoke o r carcinogens a sociated with
combu tion . The use of a va pouri zer is assoc iated with decreased
respiratory sympto ms, a nd this effect increases with th e amount of
cannab is used. Furthe m1o re, vapourizer can deliver ca nnabi s with
no carci nogeni c potenti al. This has importa nt implications for safe
use of. medi ca l mariju ana as we ll as harm reduction among
recreatwn al smokers. In o ne study, twenty frequent cannabi s users
who reported respiratory complaints were eva luated befo re and after
the use of a vapourizer for one month 33 Among participa nts who did
not develop a res piratory illness during th e trial , there was a
significant improvement in respiratory symptoms a nd FVC and a
non- ignifi cant improvement in FEY I . These improvements c~u ld be
even more meaningful in cannabi s users who al o smoke tobacco
The . authors c?ncluded, given . th ese. ~eani.n gfu l recovery of
resptratory functiOn, that a randomi zed cltnt ca l tn al of the cannabi s
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vapourizer should be performed. The va pouri zer has potential for the
administration of medical cannabis and as a harm reduction
technique, particularly for those unin terested in marijuana cessation
or who have been chronic, heavy users.

CONCLUSION
A lthough the prevalence of marijuana use has not changed
sign ificant ly in recent years, the higher cannabinoid content of
current plants may be contributing to the observed increase in rates
of dependence in ado lescents. Both phenomena - increased dose of
psychoactive drug, and increased rates of serious dependence - have
catalyzed more research into the long-term neuropsychi atric effects
of marijuana use. Long-term marijuana use is associated with an
increased risk of psychosi s and 'amotivational syndrome '. However,
the direction of causation remains unclear, not least because the risk
of marijuana dependence during ado lescence is clearly increased by
co-morbid psychiatric di sorders and has been characterized as a fonn
of 'self- medication '. Marijuana is also associated with specifi c longterm cogn itive abnormalities; the possibility of reverse causation
seems remote for these findings, but further research is needed.
Marijuana has immediate adverse effects on respiratory mucosa
simi lar to tobacco; however, evidence for chronic respiratory disease
related to marijuana is weak. For lung cancer, imilarly, heavy
marijuana use produces metaplastic changes but there is no
compelling evidence for an association w ith clinical di sease. The
contradictory evidence for both conditions may reflect differences in
the chemistry and cellular effects of marijuana as contrasted with
tobacco, as well as the high frequency of joint exposure. In that latter
regard, the more significant risk for respiratory illness, including
malignancy, may arise from the strong association of tobacco and
marijuana use, and the reduced likelihood of smoking cessation in
the presence of joint dependence.
From the standpoint of health promotion , we can draw a number
of key conclusions. Primary prevention of marijuana dependence wi ll
require health education targeting pre-adolescence. The preva lence of
comorbid psychiatric disorders in dependent adolescents highlights
the need for an integrative approach to treatment and secondary
prevention . Awareness of the conjoint use of tobacco and marijuana
is important for clinicians seeking to promote smoking cessation.
Lastly, vapourizers have the advantage of miti gating respiratory ri sk
and may serve as an effective harm reduction strategy fo r those who
are chronica lly dependent or using cannabinoids for clini ca l
indications.
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ln disaster management, where eti ologie of disease can be
unknown and every second is of the essence, a wellfunctioning inte nsive care unit (LCU) is paramo unt. The
SARS (Severe Acute Respi ratory Syndrome) outbreak in 2003
highlighted the importance of efficiency in meeting the challenges of
medi cal urgencies. In an area where resources are limited, cri ses
exacerbate c hall enges with staffi ng sho rtages and bed reducti ons,
compou nd ed by disease transmission w ithin th e lCU , staff
quarantine, emotional stre , and a constant influx of criti ca ll y ill
patients I. However, the 2003 outbreak also prese nted itself as an
opportunity to improve criti cal care delivery, with respect to
implementing better infecti on control measures, developing software
for handheld devices specific for SARS, and hav ing regul ar
teleconference call s to both combat the feelings of iso latio n and
increase information dissemination on this unknown illness 1• One
needs passion and proficiency in handling "acute medi ca l problems
where problems often come in undefi ned," says Dr. David Leasa, a
London, Ontario based ICU ph ys ician.

T

Dr. Leasa was born and rai ed in Waterloo, Ontario, and studied
Phys iology and Pharmaco logy at the University of Western Ontario
(UWO). He continued hi s studi es at UWO
in medicine and completed hi s internal
medicine residency there as we ll. After
specializi ng in Respirology and C riti ca l
Care he moved to Seattle, Washington to
pursue a year of resea rch. He moved back
to Canada, wo rked at St. Joseph's Hospita l
and later moved to University Ho pita!
where he is currentl y working as an I U
physician and Respirologist. When not in
the hosp ita l, Dr. Leasa e nj oys being
outdoors. He likes to ki (even hope for a
retirement in Whi stler!), swim , and run - all
act ivities he fee ls help him lead a balanced
healthy li fe.

ea rli er, wi th th e ai m of preve nting ICU admi ssio ns. He also has a
week in Exte nd ed ICU (E ICU) where he provides care for patients
needing prolonged ventilator care for greater than three weeks. In
additi on to ICU, he spends o ne week every 2 months on the
Respirology service taking consult . Finally, he also has a chest clinic
that is evolving into providing care for chro nica ll y venti lated
pati ents.
In the ICU, Dr. Leasa empha izes, " You need to have a team of
peo ple put forth what is the best management for that individual."
This team approach reflects th e dynamics on the wards. ln the ICU,
all the physicia ns come fro m different pecialties but have added
skills in criti cal care. (Criti cal care is an additi o nal two-year RCPSC
subspecialty after hav ing completed a base specia lty.) Dr. Leasa
admits that a he gets ol der, ICU may be too demanding (especiall y
ni g hts!) and that it wi ll be nice to be ab le to fa ll back on his
o utpati ent pract ice. He enjoys chatting with hi s pati e nts and meeting
people in this setting. This prov ides continuity with pati ents who get
very ill initiall y, but he can follow and see them in a different etting
as th ey recover - see th ei r per ona li ty and who they are as
indi viduals, o mething he cannot alway experi ence in the !CU.
However, hi s pass io n has a lways been
intensive care. He e nj oys managing a nd
problem- o lvin g acute care Res pirology
ca es in th e ICU , fro m pneum onia to acute
re piratory distress syndro me (ARDS ), to
broncho copies and pleural effu io ns.

Being a n ICU phy s ician and a
Respirol ogist is demandi ng. Dr. Leasa leads
a very act ive and busy work life. He tends
to have a week of " days" ( 12 ho ur shifts) in
I U, alternatin g with a week of " ni ghts,"
and is on-ca ll some weeke nds. During
ni ghts, a new initi ative is in place where the
ICU staff has c riti ca l care ou treach .
Qualified ICU ph ys icia ns extend their
expe rti se to o th er depa rtm ents if th ey fee l a
patie nt might end up in the ICU . By
extendin g their services outside of the ir
usual bo und ari es, th ey are ass isting patients
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Th e practice of b ot h I CU and
Respirology has led Dr. Lea a to hi s interest
in lo ng-tern1 mechani cal ventilat ion - he is
known as th e " ho me ve nti latio n doctor. " He
i presently invo lved in an initiative to
provide care for stable chroni cally venti lated
patients by moving the m from the ICU
environment to othe r community venues,
inc ludin g home if pos ibl e. Dr. Leasa
believes that "to do it safely, prope rl y and
effecti ve ly, we need to do it using a systems
approach." He wou ld want to not on ly
prevent pati e nts from e ndin g up in the ICU
agai n but also improve the ir overa ll qua lity
of life through care at ho me or in the
community. At the momen t, he is tty ing to
advocate that thi s initiative needs the proper
fundin g: if we can prevent these patients
from us ing ICU beds a nd s hift th ese
reso urces to the community, there wou ld be
benefits for all. Hi s vision for this project
Involves deve lopmg a community-ba ed

mode l for the region of South western Ontario. Currentl y there are
more than 180 patients w ho are on both non-inva ive and invasive
ve ntil atio n in our catchment area. Ventilator technology has changed
dramaticall y over the past decade including its ease of use and
increasing app lication using a noninvasive mask interface . However,
several hurdl es rema in inc luding cost, need for trained communi ty
careproviders and for patients/famil y members to be ed ucated and
empowered. Dr. Leasa is currentl y trying to create a coordinated
system of people who understand the complicated nature of the care
for these chroni call y ven til ated patients. One important task i to
identify and support those pati ents for whom chroni c ventilato r care
at home improves qua lity of life. Importantl y, this needs to be done
in a way that coordi nates all caregivers ' skill s so that pati ents do not
end up back in the ho pital. There are man y patients that can bene fit
from this type of technology (es peci a ll y those wit h chroni c
neuromuscu lar di sease), but in order to do thi s safe ly and effecti vely,
a preplanned system needs to be in place, and thi s is what Dr. Leasa
is trying to help e tabli h.
The future of critica l care holds a plethora of possibi liti es, but
also many difficult ethica l issues. Because patients in the ICU are
often amongst the sickest people in the hospita l, the difficult issue of
death and dying often arises, and proves to be a challenge for both
families and the JCU team. Dr. Leasa believe that an important step
in improving care for patients in the ICU lies in education on the
taboo subj ect of dying. Due to adva nces in med ical technology,
patients can be kept a li ve fo r longer than their bodies would natura ll y
be ab le to ustain . Difficult issues arise when one has to cons ider the
quality of life for a pati ent who is unconscious and unab le to survive
without the aid of sophisticated machinery.
Dr. Leasa is not one unfamiliar with making difficult decisions.
Recentl y, he bad to sit down with the fa mil y of a 95 year o ld man
who bad a myriad of comorbiditi es, none of which were easy to
manage. As medi cal students we learn: " primum non nocere," or
"first do no harm. " You would think that everyone would want to
give this man as comfortabl e a death as possibl e. However, hi s
fa mily expressed that he wanted to li ve unti l he was I 04, and wanted
everything possib le done for him , from intubation to chest
compressions. Perhaps it was guilt fro m neglect in previous fa mil y
confl icts, or a just desperatio n to cling onto any semblance of life
possible, but these situations are not always as clear as they appear,
neither to the family nor to the clini cian.

pl anning for surges. He notes, " If yo u stop criti ca l care, yo u stop
everything. Everything starts to back up. " He also thi nks we need
more di scussions on the ethical use of resources: not ju t at the level
of the indi vidua l, but on a soc ieta l level. He poses the question , " If
we had SA RS again, and we ran out of ve ntil ator and ICU beds what wo uld we do? Would we use a predetennined algo rithm to see
who gets a ve ntil ator and who does not?" He acknowledges that it is
difficult to have these di scus ions, but working thro ugh these
scenarios is necessary. After go ing through SARS , politic ians fin all y
understood it, even ex pressing th at " SARS was good for criti ca l ca re
- it created outreach teams, put more nurses into the system , and
looked at what 's go ing on with respect to reso urce - what they are,
and where they are."
Dr. Leasa be lieve that the general public needs to be better
educated on the purpose of the ICU, but a lso that it has its limits. He
and hi s colleagues spend a lot of their time di scuss ing what critical
care reso urces can and cannot do. Edu cation of the ge nera l public
becomes increasing ly important as the vo lume in the ICU increases.
With the current adva nce in li fe support sy tems we are abl e to
extend li fe that previously wo uld have ended . Thi s leads to new
cha ll enges. He wants peo ple to understand that we cannot cure
everything, and we cannot always delay death. Many times patients
are chroni ca ll y ill at the end of their li ves and are in a proce s of
dyi ng. Shou ld ICU care and a ventilator be part of that death
process? There is still a gap between what patients and or the ir
fam ili es ex pect and w hat our current medi ca l technol ogy can
ethicall y and reasonab ly deli ve r. Dr. Leasa is hoping we can bring the
two c loser together.
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So how do we open up and begin talking about these diffi cult
issues? Dr. Leasa believes the family unit is critical in these
di scussions. The difficulty in talking about the deteriorating health of
a loved one is trying to figure out what the patient would have
wanted for him or herself. He recall s some fa mili e who have not
seen or talked to Dad in ten years but think that prolonging care is
what he would want. As criti cal care has bettered itself with
improved communication, so too wou ld families. Dr. Leasa lives out
this philosophy, which was inspired by the mentors he has had over
the years: "The phys ic ians I learn ed a lot from were those who sat
with patients and talked honestly to them," he said, noting that they
didn 't keep a di stance but instead liked to understand the person they
were treating.
As past-president of the Canadian Criti ca l Care Society (CCCS),
Dr. Leasa has participated in many activities to enhance the quality of
care in ICUs across the country. The CCCS has guidelines on how to
assist in difficult issues at the bedside, as well as advocate for
improvement of patient and fa mil y experience in the ICU. He notes
that critical care has had its shake ups, including the SARS outbreak
which was an eye opener for governments and health care
professionals alike, but they learned that critical care had to be done
as a collective. He believes that they have been doing a good j ob in
Ontario2 in dea ling with increased occupancies and having clear
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nflammatory myofibroblastic tumo urs (IMT), also kn ow n as
plasma cell granul omas or inflammatory pseudotum ours, are the
most common paediatric primary lung tumours. 1 Pati ents present
at a mea n age of 9.7 yea rs, maki ng it an unusual adult di agnosis 2
IMTs are extremely rare, acco untin g for onl y 0.05% of all th orac ic
procedures 3 !MT bas traditi onall y been class ified as a beni gn
tum our, but recent studi e suggest loca ll y aggressive behavio ur an d
ma li g na nt pote nti a14 Radi og ra phi ca ll y, it is impos sib le to
differenti ate between an !MT and a malignant mass, 4 as the
presentation of th e tumo urs are hi ghl y vari able. IMT may be cysti c or
homogeneous, endobronchial or parenchyma1. 1 It is th ought to result
as an inflammatory reaction to an infecti on or an underl ying low
grade mali gnancy. Patie nts usuall y prese nt with loca l mass effects
with or without systemic features such as fever, weight loss,
microcytic hypochrom ic anemia, polyclo nal hyperglobulinemi a,
elevated ES R, and hype rtrophi c osteoarthropathy (HOA) 2 •4 Due to
its vari ab le natural history, compl ete surgical excision is the
treatment of choice.3

I

CASE REPORT
A 24-year-old female presented to o ur institution with a fo ur-month
history of left sided pleuritic c hest pain . The pati ent had a hi story of
hypochromic microcytic anemi a and was currentl y taki ng oral
co ntrace pti ve pill s a nd iro n s uppl e me nts. Upon ph ys ica l
examinati on, a review of systems revea led that she had a no nproducti ve co ugh, dre nching ni ght sweats, fatigue a nd had lost I 0
po unds. She a lso reported joint pai n and mo rnin g stiffn ess,
predomina ntl y in vo lving he r wrists, knees and ankl es. The pati e nt
had recentl y fini shed a ten-day co urse of a ntibi oti cs with no
symptomati c improveme nt. She was a non-s moker with occasional
marijua na a nd alco hol use. Her family hi tory wa negati ve for
mali gnan cy, but her brothe r had asthm a.
The pati ent had te ndem es to palpati o n ove r late ral c hest wa ll
on ph ys ica l examinati on. Bilateral clubbing of th e di g its wa noted .
Laboratory in vesti gati o ns revea led hypochro mic mic rocyti c
anaemia (hae moglobin leve l of 80 g! L, a mea n corpu c ul ar vo lume
of 77 . 1 fL , microcytic hypochromas ia). Chest plain fi lm showed a
mass- like conso lidatio n in the left lower lobe with enla rge ment of th e
left hilum . Computed tomograph y (CT) showed a heterogeneo us soft
ti ss ue rn a ex tendin g from th e lateral che t wa ll to th e inferi or
aspect of the left hilum . No cav itati o n or cha racteristic ca lci fi catio n
was identified. Small blood vessels we re seen within th e les ion, but
did not have th e appea rance of norm al lung vesse ls. The mass
ex tended centrall y to contact the inferior aspect of th e left hilum . No
lymph node, c hest wa ll in vas io n o r rib destru cti on we re identified .
Ex pl oratory left th o racoto my with enucleation of the tumo ur
was perform ed and an intra-operative frozen section of tumo ur (3 .2 x
2.0 x 1.5 em) showed hi stology consistent with beni gn spindle cell
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tum o ur. Fo ll ow ing this procedure, the tumour increased in size from
4.1 e m to 5.4 em over a six mo nth peri od. Thi s recurrence of the
tumour suggested locall y aggress ive behav iour; and it was decided to
perfo rm a left pneumo nectomy. Surg ica l patho logy showed no overt
cytoli c atypic, however vascul ar invasion and invo lvement of the
di aphragmatic ti ssue were evide nt. Clea r resecti o n marg ins were
ac hi eved in th e pneumonectomy and resecti on of di aphragm.
Adjuvant c hemothera py or radi at io n was not recomme nded .
DISCUSSION

Clinical manifestations
Infla mmatory myofibroblastic tumour (I_MT) is a rare tumo ur that is
mo t commonl y a ociated with th e paedi atri c po pulation . Numerous
studi es, however, bas shown that IMT can affect people of any age
and eq uall y affects both gender .2.4 It i also important to note that
IMT can occur thro ugho ut tb e body. In a review of 44 pati ents with
IMT, Ko ach et al. reported IMT occurring in the li ver, gallbladder,
orbit, medi astinum, neck soft tissue, trac hea, bowel , brain and others.
4 The orga n wi th th e hi ghest frequency of di agno is is th e lung (9 of
the 44 pati ents) 4
The presentati on of IMT depends on the locati o n of the tumour
and i influenced by local mass effects fro m the tumour size. 4 IMT
can present w ith a variety of symptoms, both syste mic and localized,
uch as anaemia, weight loss, feve r, pain, and mas .2 For example, in
thi s case, th e patient prese nted with pleuriti c chest pain .
The lung is th e most common locatio n of this neoplasm but has
been repo rted to present with ex trapulmonary symptoms . There have
onl y been a small number of case reports where hypertrophic
osteoarthropathy (HOA) was ob erved .5· 6 •7 Furthermore, these cases
occurred in children with no reported ad ult cases with HOA . The
etiol ogy o f HOA in assoc iation w ith IMT of the lung is unknown .5

Pathology
Infla mmatory myo fibrobl astic tumours pathologically consist of
myo fibrobl a tic spindle cell s with a n inflammatory ce ll infiltrate.5
The appea rance of IMT under microscopic examination is variable
both betwee n th e different site of occurre nce and between patients
with tumours in th e same location .4
The etiology of IMT is still under debate and current opini on is
changing as new information, especia ll y genetic analys i of the
tum our cell s, comes avai lab le. It was initia ll y proposed that IMT
arises from uncontrolled, excessive immune response to ti ssue injury
(most likely from infection); however, more recent studi es suggest
that it mi ght in fact be a true mali gnancy.4•8 Thi s is supported by
reports of distin ct mutations in the cell s of th ese tumo urs a nd by the
tendency for local recurre nce and invasion , distant metastas is a nd
pote ntially sarcom atous degeneration .3.4.S
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Diagnosis
A diagnosi s of IMT impossible to determine c linically as it is
genera lly a di agnosis of exclusion. Upon imaging, a mass wi ll
typically be identified ; however si nce IMTs occur with a wide range
of radiol ogical characteri stics, imag ing does not often contribute to
the diagnosis 9 Radiologica l reports on IMT, show that these tumours
can be cystic or homogenous, endobronchial or parenchymal, and
with or without clear margins.9 These qualities make IMT difficult to
distingui sh fro m infectious or ma lignant patho logies. 4·9 Furthermore,
biopsy of these les ions rarely results in a conc lusive diagnos is, as
IMT can mimic many other patho logies such as fibrous hi stiocytoma,
leiomyosarcoma or fibrom atosis.2 A confident diagno is can thus
only be made fo llowi ng surgical resection and pathological anal ysis
of the mass .s

8. van den Heuvel, D.A.; Keijsers, R.G .; van Es, H. W.; Bootsma, G.P.; de
Bruin, P.C.; Schra mel, F.M.; van Heesew ijk, J.P. In vas ive infl amm atory
myo fibroblasti c tumour of the lung. JO URN A L 2009; 4(7): 923 -926.
.K.
9. Rasa lkar, D.D.; Chu , W. .W. ; To, K.F.; C heng, F.W.T. ; Li ,
Radi olog ica l appea rance of infl ammatory myo fibrobl asti c tum o ur.
Pedi atri c Blood & Ca ncer. 20 I 0 ; 54: I 029-103 1.

Treatment
There are several treatment options to consider after IMT is
diagnosed. The first line treatment is surgical exci ion since IMTs
have the potential to local recur, be loca lly invas ive, and occasionall y
metastasize. Other suggested options include NSA IDs, steroids,
radiation, chemotherapy and observation only.
In a retrospecti ve study, 25 patients had complete resecti on of
the tumour.3 The 30-day post-operative mortality was 4% and
morbidi ty was 8%. 3 The 10-year survi va l was 89%, with one
patient's death due to extensive sarcomatous recurrence 2 years post
surgery.3 This study demonstrates that IMT has an exce llent
prognosis with compl ete surgical excision, however must still be
considered a malignancy wi th the potential to have di stant metastasis,
local recurrence and sarcomatous degeneration .3
While surgery has shown po itive results in patient cure rates,
the natural hi story of IMT has not been well studied 4 In a case
series, it was noted that local recurrence occurred in 8% of patients
where resection was attempted 4 Local recurrences tended to occur
where complete resection of the tumour was not possible or where
radiation or chemotherapy was not received 4

CONCLUSIONS
IMT is more common in the paediatric population and rare in adu lts.
However, it should be considered on the differential diagnosis when
a mass presents in a non-smoking adult. 8
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he Canadi an medi ca l tud ent, much like the Ca nadi a n publi c,
is proud of its healthca re system but believes it is in need of
e n ous refo rm . 1 The perceptio n is o ften that cost are
increasing to unsustainab le levels, with th e co nundrum th at th e
y tern still doe not deli ver a much a it hould, to as many as it
should, or in a time ly enough fas hi o n 2 In a 2011 national survey,
only 5% graded the hea lthcare y tern a excellent. However, less
th an a third of a ll res pondents be li eved they had a strong
understanding of how the healthca re ystem worked 3 How ca n one
properl y rate a syste m th ey do not understand? While medi ca l
students have a bas ic practi cal understandin g of th e medi ca l system,
th ey are found lackin g w hen it co mes to th e eco nomi c theorie and
princ iples th at govern hea lthca re.4 Thi s i not surpri sing g ive n th e
very limited tim e th at ca n be allocated out of packed medi ca l
curri culums 5 The concern neverthe less re ma ins th at medi cal stud ents
may be un equipped and unprepared for the ir future rol e in
hea lthcare reso urce a ll oca tio n a nd ma nage me nt. Witho ut a n
appreciati o n o f some bas ic tenet of hea lthca re economi cs, hav ing a
health y discussion, takin g a positi on, and making a we ll-in fo rm ed
deci ion on issues o f hea lthca re system will be diffi cult. The
purpose of this primer is to introduce to th e med ical student th e most
funda menta l economi c co ncepts and how they are pertinent to
healthcare. Ultimate ly, it will be up to th e students th emselves to
buttress th e ir kn ow ledge in thi increas ing ly important subj ect area ;
thi s editori al can onl y hope to whet th e pa late just e no ugh to
enco urage furth er ex pl orati o n.

T

HEALTH CARE IS A SCARCE GOOD
The fund amenta l probl em th at unde rlin es th e study o f economi cs is
ba ed on the s imple prem i e th at reso urce are finite w hil e hum an
needs are infinite 6 When thinkin g abo ut a tang ibl e good uch a
fossil fu e ls, the idea is easy to grasp. Everyo ne wa nt an unlimited
supp ly of fossil fu e ls to powe r th e ir ge nerators and run th e ir
machines. However beca u e thi re o urce i ca rce, there need to be
a system that decides the a ll ocati on: name ly wh o gets it and how
much they can get. Economists co ncern the mselves over the best way
thi s a ll ocation shou ld be made, and a k themse lves how thi
a ll ocati on ca n be th e mo t effi c ient while at the same time th e most
equitabl e.
When it co mes to any good produ ced in th e economy, even one
as co mplex as healthca re, the fundam enta l proble m sti ll rema ins. The
produ cti on of healthca re require th e mu lti tud e o f ra w materia ls and
suppli es required for equipment and fac ilities. In additi on, it requires
th e time and train ing of healthca re wo rker .1 All of th ese, inc ludin g
time, are ca rce resources. Indi vidua ls sell th e ir time for wages and
will even re fu se work and wage if it " isn' t worth th e ir time." Peopl e
view the ir time as a va lua ble resource th at if used for work, can no
longer be used for other acti viti e such as le isure.6 In much the arne
way, once scarce reso urces a re devoted to the production of
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healthcare, they can no lo nger be used in the production of othe r
valuab le goods. Each joul e of energy used to power a Magnetic
Resonance Imaging ( MRI ) mac hine is one that cou ld have been used
to power a school. Eac h year tra ining one doctor cou ld have been
used to train several economi sts. (It takes more resources to train a
doctor th an an economi st).
One aspect of macroeconomic theo ry tries to determine how a
nati on's scarce resources should be best a llocated between its variou
secto rs. When po licymake r decide on more MRJ s and increasing the
number of residency spot , it mea ns we have to g ive up more of
something e lse. Cons ider the foll owin g : Canada 's Gross Domestic
Product (GDP) has increased an ave rage of 1.7% ann ua ll y o ve r the
last decade.8 GDP i a measure th at adds up a ll the goods and
services that an eco nomy produces per year. This indicates that on
average, the Canadi an economy g rew by I .7% each yea r o ver the last
decade. The healthcare sector has increased by an a erage o f 4.7%
annua ll y over a s imilar peri od.9 If the entire eco no my is viewed as a
pi e, then this mea n that w hile each year the pie get a little bigger, it
has not been able to keep up with th e increasing s ize of the
hea lthcare lice. If more of the pie is be ing di tributed to healthcare,
th en less is left ove r fo r va ri ou sectors such as educat io n
agri culture, or hi g h-tech indu try. Everyone rea li ze th at healthcare i ~
important. The diffi cult questi on is how importa nt. If fo r example,
we va lue an additi ona l unit of hea lth ca re more than an addit iona l unit
of national de fe nse, th en fo regoing more de fen e fo r increased
pendin g o n hea lthca re benefit oc iety. If o ur va lue we re reversed
then additi onal spending on hea lth care wo uld res ult in Ie s sociai
bene fit. Deciding how muc h a nati on should spend o n hea lthcare is a
diffi cult questi o n beca use it ca ll into questi on o ur va lue and forces
u to a k how much we va lue hea lthca re over everything e l e.

ECONOM ICS A A SOC I AL SCIENCE: UNDERSTANDING
THE POWER OF INCENTIVES
While th e fi e ld o f modem economi cs relies on a e mpirical-based
approach with tati stical analys is, the fi e ld has it roots in the oc ial
sc iences. At its hea11 lies th e desire to understand the decisio n
makin g of individua l in the ir production or consumption of goods o r
erv1 ces 6 Econo mi sts assum e that decision makers are ratio na l and
make cho ices that be t furth er their own ends. By under tanding the
mcenll ves th at indi vid uals fa ce and how these then motivate a
parti cul ar course of acti on, economists ca n predict and the re fore
mode l the outcomes.6.7
. . W hen thi s mode ling i app lied on a larger ca le to gro up of
md1V1dual s, economists hope to better understand and predict the
consequences 111 th e eco nomy based on changi ng incentives. For
example, . w hen it comes to physicians deciding the ir location for
pract.. ce, 1ncen t1 ves ~lay a hug~ ro le .7· 10 As recently as 2006, 1 in 9
phys1c 1ans educated 111 a anad1a n med1 ca l schoo l practiced in the
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United States. 10 Therefore, they contributed nothing to the production
of healthcare in Canada. In trying to understand and reverse thi s
phenomenon, anadian economist and poli cymakers have identified
a number of incentive at play. The most famili ar is the remunerati ve
differenti al with the appeal of higher net income in certain specialti es
in the US (due in part to their lower taxation rates).'o By identi fy ing
the pertinent incenti ves, policymakers can dev ise new strategies to
alter them.
However, policymakers al o need to be care ful due to the
unde irabl e con equences that may result when all incenti ves have
not been taken into acco un t. In many cases, hidden incenti ves are
overlooked and lead to unintended consequences. For exampl e, in
the physician-patient relation hip, the phy ician is not onl y an agent
hired to act in the be t interest of the patient but is also the sell er of
health ervices. 7 In a fee-for-service compen ation method, the idea
is to compensate the physician based on the services the patients
receive. Phys ician who perform more services are thought to
provide more healthcare and should be compensated accordingly.
However, since the income of the phy ician is linked to how many
services he or she provides, there is an incenti ve to promote more
procedure than would otherwi se be nece ary. 11 These additi onal
services are not onl y wasteful fo r the economy and lower effi ciency,
but they may in fact do harm by leading to poorer outcomes in
patient who receive superfluous procedures.7•11

HOW TO COMPARE APPLES AND ORANGES: VALUATION
AND COST-BENEFIT ANALYS IS
The focus of hea lthcare di scussion is frequentl y directed at curbing
the ri sing costs, and this cost cri sis of hea lthcare dominates the
headlines. 12• 13• 14 It sometimes becomes easy to forget that we value
hea lthcare because we wa nt more of its output: health itself. The
va lue of healthcare is not in the number of patient appointment or
pill s prescribed, but in the number of li ves saved and the
improvement in health outcome. By placing a va luation on health ,
the important outcomes such as quanti ty and qua lity of life can be
mea ured and expressed. If two medi ca l intervention have
equivalent cost, and intervention A can add 3 years to life expectancy
and interventi on B onl y adds one yea r, it becomes quite clear whi ch
is superior. In evaluating any project or program, it is important to
compare the va lue of what was bought to its cost. Economi sts use
this principle of cost-benefit analysi when evaluating healthcare
programs.7
When applied on a larger sca le, it offers the potential for
comparing different healthcare interventions and even comparing
program in health and non-h ealth sectors. Noti ce that the
interventions in the examples above could have been compl etely
unrelated . Intervention A could be a cancer fi ghting drug and
intervention B a surgical procedure for coronary heart di sease. By
placing a valuation on both the inputs (the costs of production) and
the outputs (the benefits of health improvement) , unrelated
interventions can be compared. Through a comprehensive costbenefit evaluation, economic analysis can help policymakers make
difficult deci sions such as which projects to all ocate more resources
into, assessing whether a new intervention is superior to the old
standard, and in choosing between comparable alternatives 7, l6 If
applied across all healthcare sectors, policymakers can transfer
funding from high-cost low-benefit programs with the reallocation of
these resource into low-cost high-benefit programs. By minimizing
costs and maximizing benefit, the overall effect has to potential to
improve efficiency in the system and increase productivity.7· 15

CONCLUSIONS AND LIMITATIONS
Economic principles and methods offer an approach to addressing
healthcare problems. Many observers claim that economics is
irrelevant to the study of health and some have argued that health

care is fundamenta lly so di ffe rent fro m other good that fina ncial
incenti ves do not pl ay much of a role. Many will argue that when
dea ling with life and death, hea lthcare consumers cannot be expected
to maintain rati onal thinking 7 ·15 Empiri cal evidence suggests thi s is
too extreme a posi ti on.? Price and financial incentives definitely do
influence both the production and the consumption of hea lthcare. The
more challenging questi on is to what ex tent it doe . The hea lthcare
sector has a unique combinati on o f fea tures: the pro minent public
sector, restri cti ons on competiti on, and lac k o f informati on.
Combining this with the ex tensive uncertainty that ex ists both in the
suppl y and demand side of hea lthcare compli cates economi c
analyses. 7 With certain good , both suppli er and consumer have a
good understanding of the product. For example, with orange j ui ce,
upplier know how many oranges are needed to produce the juice
and are confident of the quali ty of the juice, and consumers know
how much sati sfaction they will rece ive when drinking a unit of the
juice. With hea lthcare, both the phys icians and pati ents are often
uncertain of the outcomes. Rheumatologists are often uncertain of
how pati ent will respond to a parti cular anti-infl ammatory and
pati ents themselves are un ure of the benefit to their length or quali ty
of li fe . With di ffic ulties in measuring outcome and va luation, the
accuracy of the analy is can often be ca ll ed into questi on. In the end,
modeling can onl y be as good as the info rmati on input. Nevertheless,
economi c principles and their methods can be a powerfu l and
important tool when thinking about is ues in hea ltbcare. One impl y
has to realize that li ke all too ls, economi c analysis in hea lthcare is
imperfect and subj ect to limitations.
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